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Abstract 
Rationale:  +/- 3, 4-Methylenedioxymethamphetamine (MDMA; Ecstasy) 
consumption has increased globally over the past two decades. Human 
studies have demonstrated that in a small proportion of users MDMA 
consumption may become problematic.  Limited preclinical studies have 
evaluated the abuse potential of MDMA.  
Objectives: The present study sought to determine if MDMA self-
administration has similar addictive properties as other abused 
substances.  Initial experiments sought to determine if MDMA could 
function as a reinforcer.  Subsequent experiments assessed whether 
dopamine played a role in MDMA self-administration, whether MDMA 
self-administration was maintained by the presentation of  a conditioned 
stimulus, and if extinguished MDMA self-administration could be 
reinstated.     
Methods:   Animals were surgically implanted with indwelling 
intravenous catheters that allowed delivery of MDMA solution upon 
depression of an active lever.  MDMA self-administration was examined 
in drug naïve and cocaine-trained animals.  Further assessment of the 
reliability of self-administration was assessed using a yoked procedure, 
dose effect curves were obtained, vehicle substitution occurred, and 
progressive ratio procedures were used. The underlying role of dopamine 
in mediating MDMA self-administration was determined using the D1-
like antagonist, SCH23390, and D2-like antagonist, eticlopride.  
Manipulation of the light and/or drug stimulus was used to provide initial 
assessment of the conditioning properties of MDMA.  The ability of 10 
mg/kg MDMA to reinstate responding previously maintained by MDMA 
was also determined.  
Results: MDMA was reliably self-administered in drug naïve and cocaine 
trained animals.  Responding was selective to contingent MDMA 
administration, reduced with vehicle substitution, sensitive to dose 
manipulation, and increasing demand.  A rightward shift in the dose 
effect curve was demonstrated after administration of SCH23390.  
Removal of both the light and drug stimuli produced a rapid reduction in 
responding.  Removal of either the light or drug stimulus produced a 
gradual reduction over 15 days.  Administration of MDMA reinstated 
responding previously maintained by MDMA.  
Conclusion: The demonstration of reliable MDMA self-administration 
provided a baseline for assessing MDMA abuse potential.  MDMA self-
administration was mediated by dopaminergic mechanisms which may be 
similar to those demonstrated for other abused substances.  MDMA self-
administration also produced conditioning - a feature of compulsive drug 
use.  Responding previously maintained by MDMA was later reinstated 
by MDMA, demonstrating that MDMA use may result in relapse.  
MDMA has similar behavioural properties as other commonly abused 
substances.   
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Chapter 1 - Introduction 
 
3,4-methylenedioxmethamphetamine (MDMA; ecstasy) is an 
amphetamine derivative that produces subjective effects with both 
stimulant and hallucinogenic properties (Battaglia et al 1988, Hegadoren 
et al 1999, Merck 1989, Oberlender & Nichols 1988, Paulus & Geyer 
1992).  MDMA has been categorised as an entactogen (Nichols 1986), a 
substance with both psycho-stimulant and hallucinogenic producing 
effects, with empathetic eliciting properties (Cami et al 2000, Downing 
1986, Greer & Tolbert 1986, Grob et al 1990, Grob et al 1996, Liechti & 
Vollenweider 2000, Verheyden et al 2003). 
The street names of MDMA allude to the acute positive subjective 
effects reported in both clinical and retrospective studies including; 
feelings of euphoria, increased energy, sexual and sensual arousal, 
elevated positive moods, reduction in negative thoughts, emotional 
openness, and positive depersonalisation (Cami et al 2000, Greer & 
Tolbert 1986, Hegadoren et al 1999, Liechti et al 2000, Liechti et al 2001, 
Parks & Kennedy 2004, Peroutka et al 1988, Parks & Kennedy 2004, 
Verheyden et al 2003, Vollenweider et al 1998).  Many adverse side 
effects have also been reported after chronic MDMA use; including 
increased psychopathology, impaired neuropsychological functioning and 
aversive physiological effects (Curran & Travill 1997; Greer & Tolbert 
1986; Liechti et al 2000b; Liechti & Vollenweider 2000; McCann et al 
1996; Parrott 2001; Peroutka et al 1988; Schifano et al 1998; Verheyden 
et al 2003; Wareing et al 2004; 2005; Wareing et al 2000).  
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MDMA Epidemiology and patterns of use 
MDMA consumption has been gradually increasing over the past 
decade (UNODC 2004).  Use originated in “dance” subcultures (Bellis et 
al 2003, Parrott 2001, Parrott 2004), but has spread to mainstream 
populations (Bobes et al 2002, ter Bogt et al 2006, TF & Engels 2005, 
Wilkins et al 2003), as patterns of consumption and contexts of use have 
become more variable (Degenhardt et al 2005, Topp et al 2004, von 
Sydow et al 2002).  Two major patterns of MDMA consumption are 
borne out in the epidemiological literature.  A majority of MDMA users 
have consumed less than 10 pills (Scholey et al 2004, Solowij et al 1992, 
Topp et al 1999, von Sydow et al 2002), and consume only 1 (75-100mg) 
pill on each occasion (Schifano et al 1998, Scholey et al 2004, Solowij et 
al 1992, Topp et al 1999).  Within this category, users reported 
consuming MDMA once to several times a month (Curran & Travill 
1997, Peroutka et al 1988, Schifano et al 1998, Solowij et al 1992, 
Williams et al 1998), for a discrete period of time (von Sydow et al 
2002).   
In contrast, moderate - heavy MDMA use occurs in approximately 
a third of MDMA users.  The frequency of MDMA consumption amongst 
this group of users varies considerably from once every few months 
(Solowij et al 1992), to more than once a week (Schifano et al 1998, von 
Sydow et al 2002) and binge patterns of consumption are typical (Parrott 
2001, Parrott 2004, Parrott 2005, Scholey et al 2004). One study reported 
that a third of moderate-heavy MDMA users had consumed MDMA,  
continually for approximately 48 hours on a least one occasion in the past 
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6months (Topp et al 1999), while another reported that 50% of the 
sample had consumed more than 5 pills on at least one occasion 
(Winstock et al 2001).  Binge patterns of MDMA consumption have been 
associated with increased frequency of regular MDMA use (Parrott 2005, 
Scholey et al 2004).  Those who consume MDMA in binges tend to also 
be poly drug users (Scholey et al 2004, Topp et al 1999). 
A significant proportion of moderate- heavy MDMA users met 
general DSM-IV criteria for dependence or abuse (Jansen 1999, Kurtz et 
al 2005, Topp et al 1999; Schuster et al 1998, von Sydow et al 2002). 
Increases in the amphetamine-like subjective properties of MDMA are 
hypothesised to underlie the transition from use to dependence (Jansen 
1999), as is tolerance to the positive subjective effects (Levy et al 2005, 
O'Regan & Clow 2004, Parrott 2005, Solowij et al 1992).  Moderate-
heavy users reported the development of tolerance, the presence of 
withdrawal symptoms, and the use of alternative drugs as mood 
modulators, (Forsyth 1996; Fox et al 2002; Liechti 2003; McCann et al 
1996; Parrott 2003; Parrott 2005; Peroutka et al 1988; Schifano et al 
1998; Scholey et al 2004; Shulgin 1986; Solowij et al 1992; Topp et al 
1999; Verheyden et al 2003; Verkes et al 2001; von Sydow et al 2002; 
Winstock 1991).   
A number of studies have attempted to document the consequences of 
MDMA exposure.  Unfortunately, human studies are confounded in a 
number of ways.  Patterns of consumption have relied on retrospective, 
self-report methods, which required accurate recollection and awareness 
of types, and amounts of drugs taken.  This is unlikely, given the 
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functional effects of polydrug use, and binge consumption  of MDMA .  
Additionally MDMA tablets often contain other substances, such as 
MDEA, MDA, ketamine, amphetamine, and caffeine (Parrott 2004), 
therefore, people rarely know what they are taking or how much.  
Because MDMA users exhibit high levels of poly-drug use it is difficult 
to unambiguously attribute effects to MDMA alone.  The use of animal 
models has allowed researchers to explore specific constructs, symptoms 
and mechanisms associated with addiction by controlling for a number of 
extraneous variables (Ahmed & Koob 1998, Ator & Griffiths 2003, 
Griffiths et al 1978, Koob & Le Moal 1997, Kozikowski et al 2003, 
O'Brien & Gardner 2005).  
Self-administration  
An important development in addiction research was the introduction 
of the indwelling catheter (Weeks 1962). This provided a procedure that 
allowed animals to chronically intravenously self-administer drugs. 
During the past four decades self-administration has been measured in 
many species including rhesus monkey (Segal et al 1972), 1969), squirrel 
monkey (Gerber & Stretch 1975), dog (Risner & Jones 1975), baboon 
(Griffiths et al 1976), cat (Ford & Balster 1976), rat (Pickens & Harris, 
1968) and mouse (Criswell et al 1988). 
Virtually all drugs of abuse are self-administered by laboratory 
animals, and the pattern of self-administration is comparable to the 
pattern exhibited by humans (Gardner 2000, Goldberg et al 1969, 
Griffiths & Balster 1979, Griffiths et al 1978, Pickens & Harris 1968, 
Segal et al 1972, Spealman & Goldberg 1978).  A focus of early research 
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was to demonstrate reliable self-administration and to identify drugs with 
abuse potential.  The abuse liability of a substance is defined by the 
likelihood that a substance can maintain ‘non-medical self-administration 
resulting in disruptive or undesirable consequences’ (FDA, pg 3).  
Therefore demonstration of reliable self-administration has been deemed 
necessary in the preclinical evaluation of substances with abuse potential 
(Ator & Griffiths 2003, Kozikowski et al 2003).        
To convincingly demonstrate reliable self-administration operant 
behaviour must be selective (Ahmed & Koob 1998, Fischman & Schuster 
1978, Griffiths & Balster 1979, Griffiths et al 1978, Koob 1992, O'Brien 
& Gardner 2005, Spealman & Kelleher 1981, Thompson 1981).   This 
can be established through various methods, including simple-choice 
procedures and yoked procedures.  When simple- choice procedures are 
employed, depression on one lever (active) results in drug delivery, while 
depression on another (inactive) lever has no programmed consequence, 
or produces delivery of a vehicle solution.  Significant preference for the 
active lever suggests that a drug is reinforcing (Brady & Griffiths 1976, 
Griffiths et al 1978, Griffiths et al 1981).  Yoked self-administration 
procedures also determine whether a drug is reinforcing.  Under these 
conditions one animal receives drug delivery contingent on performance 
of the appropriate operant (Pickens & Crowder 1967, Yokel & Pickens 
1974).  Yoked animals receive either vehicle or drug infusions dependant 
on the contingent animal’s responses.  An elevated level of responding by 
only the response contingent animal, demonstrates selective self-
administration behaviour.  Once self-administration has been 
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demonstrated, it is also convincing to show extinction when vehicle 
solution is substituted for the drug (Yokel & Pickens 1973).       
In self-administration experiments, responding is often 
demonstrated in a dose-dependant fashion (Arnold & Roberts 1997, 
Bickel et al 1990, Griffiths et al 1978, Winger et al 1989, Yokel & Wise 
1976).  Low doses of a drug are often too small to reinforce responding.  
In contrast, a threshold dose of a drug will maintain high levels of operant 
responding.  Thereafter responding is generally inversely related to the 
dose of drug (Griffiths et al 1976, Yokel & Wise 1976).  Fixed ratio dose-
dependant responding is depicted in the shape of an inverted U (see 
Figure 1), and this has been demonstrated for many different self-
administered substances (Ator & Griffiths 1983; Downs & Woods 1975; 
Goldberg et al 1971; Griffiths et al 1976; Harrigan & Downs 1978; 
Martin et al 1996; Meisch & Stewart 1994; O'Brien & Gardner 2005; 
Risner & Jones 1980; Schenk & Partridge 1997; Wilson et al 1971; 
Winger et al 1989; Woolverton et al 1980; Yokel & Wise 1976; Yokel & 
Pickens, 1973).  When doses higher than threshold are available the rate 
of drug intake is inversely related to the injection dose.   It is possible that 
the reductions in responding may be due to the rate-decreasing effects of 
high doses of a drug.  For example, high levels of responding may be due 
to increased stereotyped behaviour (Patel et al 1996), however, this is 
unlikely as higher doses of a substance increase rather than decrease 
stereotyped behaviour.  Furthermore, stereotyped behaviour is unlikely to 
directly influence specific drug-taking behaviours (Wise et al 1977).  It is 
also possible that reductions in responding seen at high doses are due to 
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the toxic effects of a substance.  The rate –decreasing effects of high 
doses are unlikely to be due to toxicity, as animals will acquire self-
administration more rapidly when higher doses of a substance are used 
(Schenk et al, 1993; Carroll & Lac, 1997).  A more likely explanation for 
the inverse relationship between unit dose and responding, is that an 
animal is titrating blood-brain levels of a substance through 
compensatory responding (Hurd et al 1989, Pettit & Justice 1989, Pettit & 
Justice 1991, Ranaldi et al 1999, Wise et al 1995, Wise et al 1995). For 
example, within-session analysis of response rate and blood levels of d-
amphetamine revealed that rats performed an operant response when 
blood levels fell below 0.2µg/ml (Yokel & Pickens 1974).  Microdialysis 
studies have also confirmed that responding maintained by cocaine is 
associated with reductions in elevated dopamine levels (Wise et al, 
1995b).    
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Figure 1: Dose effect curve 
Adapted from Yokel & Pickens (1973).   
Mean injections per hour for Methamphetamine and amphetamine.   
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 Self-administration procedures can also be used to determine the 
incentive motivational properties of a substance (Griffiths et al, 1979; 
Arnold & Roberts, 1997; Richardson & Roberts, 1996).  Increasing Fixed 
Ratio (FR) schedules of reinforcement produced  an increased rate of  
responding demonstrating increased motivation and incentive to self-
administer a substance, as a function of demand (Dworkin et al 1984, 
Goldberg & Henningfield 1988, Lemaire & Meisch 1984, Lemaire & 
Meisch 1985, Spealman & Goldberg 1978, Weeks & Collins 1978).   The 
behavioural consequences of increased demand can also be demonstrated 
through use of the progressive ratio (PR) procedure (Arnold & Roberts 
1997, Griffiths et al 1978, Li et al 1994, Li et al 2003, McGregor & 
Roberts 1995, Reid et al 1995, Shaham & Stewart 1994).  In this 
procedure, the operant response requirement for delivery of a reinforcer 
increases in a step like fashion, until the requirement is so high that 
responding is no longer maintained – this point is referred to as the break 
point.  Therefore, it is possible to determine the maximal level of 
behaviour or effort an animal will exert in order to receive a self-
administered injection (Arnold & Roberts 1997, Foster et al 1989, 
Griffiths et al 1978, Patel et al 1996).   Dose-response curves under 
progressive-ratio schedules demonstrate the reinforcing efficacy of a 
substance (Arnold & Roberts 1997, Foster et al 1989, Griffiths et al 1978, 
Patel et al 1996).  Low doses of cocaine, GBR 12909, heroin, 
amphetamine and methamphetamine produced low breakpoints, as the 
unit dose increased the breakpoint increased (Foster et al 1989, Griffiths 
et al 1978, Roberts 1993, Roberts & Bennett 1993).  
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Despite the documentation of reliable self-administration of many 
commonly abused drugs (Ator & Griffiths 2003, Balster & Lukas 1985, 
Griffiths et al 1979, Griffiths et al 1981), self-administration of some 
substances widely abused by humans has not been easily demonstrated in 
animals.  For example, reliable nicotine self-administration was difficult 
to demonstrate for many years (Hanson et al 1979, Lang et al 1977, Slifer 
& Balster 1983).  However manipulation of experimental protocols such 
as reducing the dose, and allowing limited access produced robust self-
administration (Corrigall 1999, Corrigall & Coen 1989, Corrigall & Coen 
1991, Rose & Corrigall 1997).  Subsequently, it was demonstrated that 
responding under some conditions was dose dependently reduced by 
some antagonistic pharmacological treatments and reduced following 
saline substitution (Corrigall & Coen 1989).   
Initial attempts to demonstrate self-administration of ∆-9 THC were 
also inconclusive (Lew & Richardson 1981, Mansbach et al 1994, 
Takahashi & Singer 1979, Takahashi & Singer 1981).  These findings led 
to varying explanations including (1) that ∆-9 THC was not a drug of 
abuse, (2) that the self-administration paradigm had reduced validity, (3) 
that the delayed effects of ∆-9 THC prevented operant conditioning and, 
(4) that ∆-9 THC was a depressant on operant behaviour (see (Tanda & 
Goldberg 2003)).  Subsequent manipulation of experimental procedures 
including solution concentration, infusion speed and infusion duration 
resulted in  reliable dose-dependant self-administration (Tanda & 
Goldberg 2003, Tanda et al 2000). 
MDMA Self-administration     - 16 - 
 - 16 - 
The demonstration of reliable and robust nicotine and ∆-9 THC self-
administration despite initial claims that they were both weak reinforcers, 
indicates that a degree of caution in interpretation is required if a 
substance with known abuse potential in humans does not initially 
produce reliable self-administration.  Furthermore, false negatives can be 
produced unless a variety of experimental procedures are employed.  
MDMA self-administration 
The establishment of reliable and replicable MDMA self-
administration has largely evaded self-administration researchers and 
only a handful of studies have been published (Beardsley et al 1986b; 
Braida & Sala 2002; Cornish et al 2003; Fantegrossi 2007; Fantegrossi et 
al 2002; Fantegrossi et al 2004; Lamb & Griffiths 1987; Lile et al 2005; 
Ratzenboeck et al 2001; Reveron et al 2006; Trigo et al 2006; Wang & 
Woolverton 2007).   
Substitution studies have demonstrated that MDMA can  
reinforceoperant behaviour (Beardsley et al 1986, Fantegrossi 2007, 
Fantegrossi et al 2002, Fantegrossi et al 2004, Lamb & Griffiths 1987, 
Lile et al 2005).  Initial MDMA self-administration studies in cocaine-
trained primates demonstrated that operant responding maintained by 
MDMA was higher than operant responding maintained by saline 
(Beardsley et al 1986, Lamb & Griffiths 1987).  Lamb & Griffiths (1987) 
reported that MDMA self-administration produced lower levels of 
responding when compared to cocaine, and the data were characterised 
by high levels of variability amongst animals and between sessions.  
Fantegrossi et al (2002; 2004; 2007), Lile et al (2005) and Wang & 
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Woolverton (2007) have extended these findings.  Animals were trained 
to self-administer cocaine on a daily basis and MDMA- racemic, S (+), 
and R (-) was substituted for cocaine (Fantegrossi et al 2002, Fantegrossi 
et al 2004, Lile et al 2005).  Dose dependant self-administration of 
racemic MDMA and its stereoisomer’s was demonstrated (Fantegrossi et 
al 2004).    Lile and colleagues (2005) employed the same methodology 
with baseline behaviour maintained by cocaine, and a progressive ratio 
procedure was used to examine MDMA self-administration.  MDMA 
maintained responding in a dose-dependant manner and a maximal mean 
breakpoint of 802 was obtained when PR schedules were employed.  
Breakpoints for all animals increased as the dose of MDMA (0.01-
1.0mg/kg) increased (Lile et al 2005).  Subsequently, Wang & 
Woolverton (2007) also demonstrated a dose dependant increase in 
breakpoint for MDMA self-administration (0.05-0.8 mg/kg/infusion), 
with comparable maximal rates of responding as those reported by Lile et 
al (2005).       
Several studies have attempted to produce reliable MDMA self-
administration in laboratory rats.  Ratzenboeck and colleagues (2001) 
demonstrated MDMA (0.032-10mg/kg/infusion) self-administration in 
drug-naïve and cocaine –trained rodents.  Low rates of operant 
responding were observed, however, leading to the suggestion that 
MDMA was a weak reinforcer (Cole & Sumnall 2003, Newton et al 
2006, Ratzenboeck et al 2001).  Alternatively, the acquisition methods 
used by Ratzenboeck et al (2001) may not have engendered optimal 
operant responding. Typically, in order for self-administration behaviours 
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to be established, repeated consistent discrete pairings of a drug-lever and 
drug delivery are required (Griffith et al, 1979).  In the study conducted 
by Ratzenboeck et al (2001) animals received multiple discrete, MDMA, 
cocaine, and saline self-administration sessions per day.  This may have 
intervened with the ability to acquire operant contingency due to 
inconsistent reinforcers.  In addition, the comparatively long half-life of 
MDMA when compared to cocaine may have limited the possibility of 
distinguishing rates of responding for cocaine and MDMA.      
Following the study conducted by Ratzenboeck et al (2001), four 
other studies have demonstrated MDMA self-administration in rats 
(Braida & Sala 2002, Cornish et al 2003, Newton et al 2006).  Braida & 
Sala (2002) trained animals to receive intracerebroventricular (ICV) 
infusions of MDMA (0.01-2µg/infusion) according to an FR1 schedule 
during daily 1-h sessions.  Animals acquired MDMA self-administration 
and self-administration was dose-dependant (Braida & Sala 2002).  
Cornish et al (2003) also reported dose dependant MDMA self-
administration (0.1-1.0mg/kg/infusion; FR1, daily 2-H sessions).  The 
acquisition of MDMA self-administration (1.0mg/kg/infusion) was also 
demonstrated by Reveron et al (2006), with responding increasing as the 
dose of MDMA made available was halved.                     
One other study has investigated MDMA self-administration in 
rats (De La Garza et al 2006).  In one group, (N=5), animals were 
allowed access to MDMA (0.75mg/kg/infusion) according to an FR2 
schedule of reinforcement for 24 daily 3-h sessions.  In a second group 
(N=15), similar acquisition conditions were imposed, although the dose 
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of MDMA was reduced to 0.375mg/kg/infusion. Responding maintained 
by MDMA was comparable to responding maintained by saline in four 
out of five rats leading to the conclusion that MDMA was not as potent 
reinforcer as other commonly abused substances (De La Garza et al 
2006).  Low rates (2-7 responses) of responding were produced when 
animals were tested during the light phase of their circadian rhythms.  
When session times were extended to 12-h and animals were run in the 
dark phase of their circadian rhythm, responding maintained by MDMA 
increased to 8-12 infusions per session. Reduction of MDMA dose 
(0.1875mg/kg/infusion) during one session produced a reduction in 
responding.  Responding failed to return to prior levels of responding 
when the initial dose was again available.  Saline substitution reduced 
responding further but responding was not reinstated when MDMA was 
reintroduced. These authors also concluded that MDMA was a weak 
reinforcer.  Unfortunately, only limited conditions were examined.  It is 
equally possible that MDMA is a more effective reinforcer under 
different parameters.  Additionally, responding was averaged across all 
days of acquisition and a mean response /day rate was presented. There is 
generally a protracted period of acquisition of self-administration with 
responding increasing gradually over days (Campbell & Carroll 2000, 
Deminiere et al 1989, Schenk & Partridge 2000).  Therefore averaging 
data over this period might obscure reliable responding that might appear 
during later sessions. In addition, the use of small samples, single case 
examples, and the absence of statistical analysis renders this study 
inconclusive.  
MDMA Self-administration     - 20 - 
 - 20 - 
In order to further examine MDMA self-administration, a 
substitution paradigm will be used in this thesis to determine whether 
MDMA maintains responding in cocaine-trained rats.  Acquisition of 
self-administration in drug naïve rats will also be examined.  The 
selectivity of operant behaviours will also be assessed using a simple 
choice and a yoked self-administration procedure.  Dose effect curves 
will be assessed and the effects of vehicle substitution will be measured. 
The effects of increasing demand will also be evaluated by manipulating 
schedules of reinforcement, and through the use of a P.R. schedule.    
Pharmacology of drug abuse 
 A wealth of evidence has indicated that excitation of the  mesolimbic 
dopaminergic tracts projecting from the ventral tegemental area (VTA) to 
the ventral striatum (nucleus accumbens; Nuc Accum), amgydala and 
frontal cortex is critical for  the acute reinforcing effects of drugs of abuse 
(Carelli 2004; Carr et al 1988; Di Chiara 1999; Di Chiara et al 2004; 
Fibiger et al 1992; Koob & Hubner 1988; Koob & Weiss 1990; Pulvirenti 
& Koob 1990; Ranaldi et al 1999; Robinson & Berridge 1993; 2000; 
Sahakyan & Kelley 2002; Salamone & Correa 2002; Wise 1984; 1987; 
1998; Wise & Bozarth 1982; 1985; Wise et al 1995b; Wolf 2002).  PET 
scans have shown that reported positive subjective experiences are 
correlated with occupancy of the dopamine reuptake transporters (DAT) 
in experienced cocaine users (Volkow et al 1999, Volkow et al 1997), and 
long-term alterations in the D2-like receptor density in the striatum are 
found in chronic drug users (Volkow et al 2001, Volkow et al 2002, 
Volkow et al 1993).    
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Despite having varied pharmacological effects, self-administered 
substances all produce direct and/or indirect effects on dopaminergic 
systems. Administration of some psychostimulants resulted in direct 
increases in synaptic dopamine.  For example, d-amphetamine binds 
directly to the DAT, causing a reversal of functioning and stimulating 
release (Pierce & Peroutka 1988), while cocaine blocks the DA 
transporters (Canfield et al 1990, Porrino et al 1989, Ritz et al 1987, Ritz 
et al 1988).  In contrast, other drugs are indirect dopamine agonists, 
acting on neural substrates which interact with the mesolimbic dopamine 
system.  For example, opiates produced stimulation of the dopamine 
system through activation of the mu- opioid receptor which inhibits 
GABBAergic neurons thereby disinhibiting DA neurons (Eidelberg & 
Erspamer 1975).  Microdialysis studies have shown that administration of 
self-administered substances including cocaine, amphetamine, nicotine, 
opiates and PCP, preferentially stimulated dopamine transmission in the 
nucleus accumbens and VTA (Bassareo et al 1996, Di Chiara & Imperato 
1988, Imperato et al 1992, Imperato et al 1996, Kuczenski et al 1997).      
Several lines of evidence have implicated dopaminergic 
mechanisms in drug self-administration. Firstly, both direct and indirect 
dopamine agonists are readily self-administered (Howell & Byrd 1991, 
Nader & Mach 1996, Roberts et al 1999, Self & Stein 1992, Weed & 
Woolverton 1995, Woolverton et al 1984, Yokel & Wise 1978).  Pre-
treatment with dopaminergic agonists reduced subsequent drug self-
administration, suggesting a leftward shift in the dose response curve and 
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an increased potency of the self-administered drug (Swerdlow et al 1991, 
Yokel & Wise 1978).   
Secondly, selective neurotoxic lesions with 6-hydroxydopamine 
(6-OHDA) disrupted self-administration (Iannone et al 2006, Lyness et al 
1979, Roberts & Koob 1982, Smith et al 1985).  6-OHDA lesions to the 
nucleus accumbens produced a 90% reduction in dopamine and 
attenuated cocaine maintained responding for at least 15 days (Roberts et 
al 1977).  In addition, 6-OHDA lesions to the Nuc Accum abolished the 
acquisition and maintenance of amphetamine self-administration (Lyness 
et al 1979).  6-OHDA lesions of cell bodies in the VTA disrupted 
responding maintained by heroin, cocaine and morphine (Bozarth & Wise 
1986, Roberts & Koob 1982).  Lesions to the medial prefrontal cortex  
(MPFC) had no effect on the maintenance of d-amphetamine or cocaine 
self-administration under simple FR schedules (Leccese & Lyness 1987, 
Martin-Iverson et al 1986, McGregor et al 1996, Peltier & Schenk 1991), 
but 6-OHDA lesions to the MPFC increased breakpoints maintained by 
low doses of cocaine and apomorphine under PR schedules (Foster et al 
1989, Lin et al 1994, McGregor et al 1996).  These findings may indicate 
an increase in the sensitivity of the dopamine systems in the mPFC after 
repeated exposure to drugs of abuse.   6-OHDA lesions were selective 
and had no effect on responding maintained by food and water (Dworkin 
et al 1988, Smith et al 1985), suggesting a selective role for the 
mesocorticolimbic system projections in drug self-administration.   
Thirdly, pharmacological manipulations of dopamine also modify 
drug self-administration.  Pre-treatment with the D2 receptor antagonist, 
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chlorapromazine, increased responding maintained by cocaine, 
amphetamine, and methylphenidate in rhesus monkeys (Wilson & 
Schuster 1972).  The increase in responding seen after antagonism is 
consistent with a rightward shift in the dose-response curve.  
Subsequently, self-administration of many substances including, opioids 
(Corrigall & Vaccarino 1988, Shippenberg & Elmer 1998), alcohol 
(Pfeffer & Samson 1985), nicotine (Corrigall & Coen 1991, Tanda et al 
1999, Wilson et al 1992), THC (Tanda & Goldberg 2003, Tanda et al 
1999), cocaine (Bergman et al 1990, Caine & Koob 1994, Corrigall & 
Coen 1991, Hubner & Moreton 1991, Koob et al 1987, Ranaldi & Wise 
2001, Woolverton & Virus 1989), amphetamine (Phillips et al 1994), and 
diazepam (Pilotto et al 1984) were modified by pharmacological 
manipulations of dopamine.  
Pharmacological antagonism of D1-like receptors produced a 
rightward shift in the dose effect curves for amphetamine, morphine, and 
cocaine self-administration (Anderson et al 2003; Bari & Pierce 2005; 
Barrett et al 2004; Caine & Koob 1994a; Corrigall & Coen 1991a; Di 
Ciano et al 1995; Hubner & Moreton 1991; Koob et al 1987; Maldonado 
et al 1993; Pich & Epping-Jordan 1998; Pierre & Vezina 1998; Quinlan et 
al 2004; Ranaldi & Wise 2001; Rodriguez De Fonseca et al 1995; 
Swerdlow et al 1991; Weed et al 1998; Yui et al 1997).   Antagonism of 
the D2-like receptors produced similar effects.  For example, pre-
treatment with chlorpromazine, a D2-like receptor antagonist produced a 
dose dependant increase in cocaine self-administration (Wilson & 
Schuster 1972, Woods et al 1988). The production of a rightward shift in 
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the dose-effect after D2-like receptor antagonism has been demonstrated 
with amphetamine-, cocaine- and morphine- self-administration (Caine & 
Koob 1994, Corrigall & Coen 1991, David et al 2002, Haile & Kosten 
2001, Hubner & Moreton 1991, Swerdlow et al 1991, Weed et al 1998, 
Yui et al 1997)).  Pre-treatment with D1-like and D2-like receptor 
antagonists reduced the breakpoints for cocaine, amphetamine and opiate 
self- administration under a progressive ratio schedule (Bari & Pierce 
2005, Hubner & Moreton 1991, Izzo et al 2001, Lin et al 1993, Ranaldi & 
Wise 2001, Ward et al 1996) consistent with a rightward shift in the dose 
effect curve, and a decrease in the potency of the self-administered 
substances.  These data provided further evidence that dopamine receptor 
activation is required in order to maintain self-administration.  
Fourthly, microdialysis studies have been used to measure 
synaptic overflow of neurotransmitters and major metabolites (Ranaldi et 
al 1999, Wise et al 1995, Wise et al 1995).  Cocaine, heroin, and 
amphetamine self-administration dose-dependently increased 
extracellular levels of dopamine in the nucleus accumbens (Hemby et al 
1997, Pettit & Justice 1989, Pettit & Justice 1991, Ranaldi et al 1999, 
Wise et al 1995, Wise et al 1995).  Within session levels of dopamine 
were increased immediately after drug delivery, and gradually declined 
until a subsequent operant response was performed (Hurd et al 1989, 
Pettit & Justice 1989, Pettit & Justice 1991, Ranaldi et al 1999, Wise et al 
1995, Wise et al 1995).  Animals typically self-administered several 
infusions during the initial phases of self-administration (loading up 
phase) during which time rapid increases in extracellular dopamine were 
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reported (Ranaldi et al 1999, Wise et al 1995, Wise et al 1995).  
Following the initial loading up phase, phasic fluctuations in dopamine 
levels were associated with drug infusions, providing further evidence 
that operant responding was tied to a decrease in elevated dopamine 
levels (Ranaldi et al 1999, Wise et al 1995, Wise et al 1995). 
While a clear dopaminergic role has been implicated in self-
administration, the function of other neurotransmitter systems has also 
been investigated.  Of relevance to the current thesis, serotonergic 
mechanisms have been implicated. Lecesse & Lyness (1984) reported 
reductions in amphetamine self-administration after pre-treatment with 
the serotonergic antagonists, cyproheptadine and methysergide, and 
Porrino et al (1989) reported that cinanserin, a 5-HT2 receptor antagonist, 
reduced amphetamine maintained responding.  Cocaine self-
administration, however, remained unchanged after pre-treatment with 5-
HT3 antagonists GR38032F, and MDL 72222, 5-HT2A antagonists, 
ketanserin, and 5-HT1/2-antagonist, methysergide (Lacosta & Roberts 
1993, Peltier & Schenk 1991).  Further complicating interpretation, pre-
treatment with the 5-HT reuptake inhibitors, fluoxetine and 
dexfenfluramine also reduced responding maintained by amphetamine 
and heroin (Higgins et al 1994, Leccese & Lyness 1984, Porrino et al 
1989).  It is likely that these effects may vary as a function of the 
interaction between antagonist dose used and levels of extracellular 5-HT, 
as some receptors require specific elevations of 5-HT prior to activation 
(Bankson & Cunningham 2002).  Furthermore, interactions between the 
serotonin and dopamine system have been demonstrated.  For example, 
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activation of the 5-HT2c receptor is known to inhibit Nuc Accum and 
dorsal striatum dopamine release (Alex et al, 2005; Navailles et al, 2006).    
The role of dopamine in self-administration of many drugs of 
abuse is supported by a wealth of data, but the pharmacology of MDMA 
self-administration has not been established.   
Pharmacology of MDMA 
MDMA initially produces a rapid increase in extracellular 5-HT and 
DA (Colado et al 1993; Gudelsky & Nash 1996; Gudelsky et al 1994; 
Johnson et al 1986; Koch & Galloway 1997; McKenna & Peroutka 1990; 
O'Loinsigh et al 2001; Sabol & Seiden 1998; Schmidt et al 1987; Schmidt 
et al 1986; Stone et al 1987; White et al 1996; Yamamoto et al 1995).  
MDMA acts directly on the serotonin transporter, inhibiting 5-HT 
transport across plasma walls leading to a reduction in 5-HT reuptake and 
increases in extracellullar 5-HT (Cole & Sumnall 2003, Gudelsky & Nash 
1996, Mechan et al 2002, Rudnick & Wall 1992, Schmidt et al 1987).  
MDMA also has direct affinities for  the 5-HT receptors (Battaglia et al 
1988, Koch & Galloway 1997, Schmidt & Taylor 1990).  These 
mechanisms have been the focus of investigation for much research, and 
significant evidence indicates that activation of serotonin receptors are 
involved in the anxiogenic- (McGregor et al 2003, Morley et al 2005, 
Sumnall et al 2004) and hyperactive- (Callaway et al 1992, Callaway et al 
1990, Fletcher et al 2002, Gold & Koob 1988, Gold et al 1988, Kehne et 
al 1996, McCreary et al 1999) effects of MDMA.  For example, selective 
5,7-DHT lesions and antagonism of the 5-HT1B, 5-HT2A, and 5-HT2B 
receptors attenuated MDMA –induced hyperactivity (Callaway et al 
MDMA Self-administration     - 27 - 
 - 27 - 
1990, Kehne et al 1996, McCreary et al 1999).  Pre-treatment with 5-
HT2C receptor agonists, however, also attenuated MDMA-induced 
hyperactivity (Fletcher et al 2002, Gold & Koob 1988), indicating 
differential roles of the 5-HT receptor subtypes in MDMA –induced 
behaviours.   
   MDMA also produces pronounced effects on dopamine 
neurochemistry via direct and indirect mechanisms.  MDMA- induced 
inhibition of the dopamine transporter (DAT), increased DA synthesis, 
and inhibition of MAO,produced an increase extracellular dopamine 
levels (Crespi et al 1997, Nash & Brodkin 1991, Shankaran & Gudelsky 
1998, White et al 1994, Yamamoto & Spanos 1988).  MDMA 
administration produced a time- and dose- dependant increase in 
dopamine levels in the caudate nucleus and in the Nuc Accum , as 
measured by in vivo volumetry and HPLC methods (Yamamoto & 
Spanos 1988).  MDMA increased dopamine levels in a dose dependant 
manner (0.32mg/kg-3.2mg/kg) preferentially in the Nuc Accum shell 
compared to the Nuc Accum core (Cadoni et al 2005 ,Di Chiara et al 
1999).  The enhancement of synaptic dopamine was of longer duration 
than the enhancement of synaptic 5-HT (Johnson et al 1986, Mayerhofer 
et al 2001, O'Shea et al 2005, Stone et al 1986, White et al 1994) and a 
delayed secondary increase in dopamine levels in the nucleus accumbens 
has also been reported (Koch & Galloway 1997, White et al 1994, 
Yamamoto et al 1995).  Several studies have implicated DA mechanisms 
in the effects of MDMA.  MDMA-induced excitation of striatal neurons 
was associated with increased hyperactivity, delayed after D1-like 
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receptor antagonism, and attenuated by D2-like receptor antagonism (Ball 
et al 2003).  6-OHDA lesions to the nucleus accumbens and systemic pre-
treatment with D1-like and D2-like receptor antagonists attenuated the 
locomotor activity effects of MDMA (Gold et al 1989, Kehne et al 1996).   
Furthermore, the expression of MDMA-induced locomotor sensitisation 
was inhibited by pre-treatment with the D1-like antagonist, SCH23390 
(Ramos et al 2004).  These data suggest that the behavioural effects of 
MDMA are at least partially mediated by dopaminergic mechanisms.    
Evidence for the modulation of DA release by MDMA-induced 
elevations in 5-HT has been reported.  Pre-treatment with the selective 
serotonin reuptake inhibitor (SSRI) fluoxetine partially attenuated 
MDMA-induced elevations of striatal dopamine (Koch & Galloway 
1997).  The reductions in dopamine after SSRI pre-treatment are likely to 
be due to competitive antagonism of the SERT, reducing MDMA-
induced serotonin.    Initial studies demonstrated that direct 5-HT2-
receptor agonism with DOI, and 5-MeODMT, potentiated MDMA-
induced DA release (Gudelsky et al 1994).  Activation of different 5-HT2 
receptors can have differential effects on dopamine release.  Activation of 
5-HT2A and 5-HT1B receptors increased dopamine release (Lucas & 
Spampinato 2000, Yan 2000), and antagonism of these receptors reduced 
MDMA-produced dopamine increases (Lucas & Spampinato 2000, 
Schmidt et al 1994).  In contrast, antagonism of the 5-HT2C receptors in 
the VTA, resulted in reductions in VTA GABBA, which in turn 
disinhibited Nuc Accum DA release (Bankson & Yamamoto 2004).  Both 
the 5-HT2A and 5-HT2C receptors have a relatively low affinity for 
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serotonin, therefore low doses of MDMA are unlikely to activate these 
receptors.  These modulatory mechanisms may explain changes in the 
locomotor activating effects of MDMA after serotonergic pre-treatment.  
Further evidence for this hypothesis has been obtained from 
electrophysiology studies, as antagonism of the 5-HT2A receptor 
attenuated both MDMA-induced locomotor activity and striatal 
excitation; in contrast, antagonism of the 5-HT2C receptor had no effect 
on locomotor activity or striatal excitation (Ball & Rebec 2005).   
The mechanisms underlying MDMA reinforcement in both humans 
and animals are poorly characterised and it is currently unclear whether 
dopamine is a critical neurotransmitter underlying the reinforcing effects 
of MDMA.   Two studies have reported that the euphoria producing 
effects of MDMA may be due to dopaminergic mechanisms.  In one, pre-
treatment with the dopamine antagonist, haloperidol, reduced the 
subjective ratings of positive mood and ‘mania’ produced by MDMA 
(Liechti & Vollenweider 2000).   In another, MDMA users reported 
preferences for MDMA or d-amphetamine when compared to the 
serotonergic agonist MCPP, as measured by a multiple cost-benefit 
choice preference procedure (Tancer & Johanson 2003).  These data 
indicate that in humans, MDMA was more reinforcing than a direct 
serotonergic agonist, and at least as reinforcing as a dopamine agonist.  
Animal studies attempting to characterise the pharmacology of 
MDMA reinforcement and reward have focused on serotonergic 
mechanisms.   In one study pre-treatment with high doses of the 5-HT1A 
agonist, 8-OH-DPAT attenuated MDMA self-administration in rats (De 
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La Garza et al, 2006).   In another study, the non-selective 5-HT2A/C 
receptor antagonist, Ketanserin and 5-HT2A receptor antagonist, MDL 
100907, produced differential effects on responding maintained by 
racemic MDMA, S(+) MDMA and R(-) MDMA (Fantegrossi et al, 
2006).  Ketanserin produced a general reduction in responding for all 
three forms of MDMA.  While MDL 100907 failed to significantly alter 
responding maintained by racemic MDMA.  A rightward shift in the  
ascending limb of the S (+) MDMA dose effect curve, and attenuation of  
responding maintained by R (-) MDMA was found.  These findings 
might be related to differential effects of the different isomers on DA 
neurotransmitters.  S (+) - and R (-) - MDMA differentially activated DA 
and 5-HT systems, with the former producing greater DA effects and the 
later producing greater 5-HT effects (Baker et al 1995, Battaglia & 
Napier 1998).  The changes in self-administration behaviour seen after 5-
HT antagonism indicates that 5-HT mechanism are involved in MDMA 
self-administration.  Given the wealth of data implicating dopamine in 
self-administration, the alterations in MDMA self-administration seen 
after 5-HT receptor antagonism may also be due to the serotonergic 
effects on DA release (Fantegrossi et al, 2006).    
In order to evaluate the role of dopamine in MDMA self-
administration, the second major experiment conducted for this thesis will 
determine the effects of the D1-like and D2-like receptor antagonists on 
MDMA self-administration.  The D1-like receptor antagonist, 
SCH23390, and the D2-like receptor antagonist, eticlopride, will be used 
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in both self-administration and locomotion studies to determine if the 
effects of MDMA are sensitive to dopaminergic manipulations.  
Transition from use to abuse and dependence 
 Pathological drug use has been defined as the development of 
compulsive drug taking, and an inability to cease drug consumption 
(Koob 2006, Robinson & Berridge 2000).  There are specific features that 
characterise compulsive drug-taking and differentiate drug abuse and 
dependence from drug use. Compulsive drug-taking elicits subjective 
states not produced by controlled drug taking.  Inexperienced drug users 
did not report a state of ‘craving’, whereas experienced cocaine users 
reported, and differentiated the state of ‘craving’ from the state of being 
‘high’(Childress et al 1988, Childress et al 1986, Ehrman et al 1990, 
Haney et al 1999, O'Brien et al 1992, O'Brien et al 1992, Robinson & 
Berridge 1993).  Experienced drug users reported that exposure to drug 
associated cues, and threshold doses of a substance, elicited states of 
craving and motivation to consume a substance (Carter & Tiffany 1999; 
Childress et al 1988, Childress et al 1986, Childress et al 1986, Ehrman et 
al 1991, Panlilio et al 2005).  Experienced drug users also reported a 
reduction in the subjective effects of higher doses of a substance (Ward et 
al, 1997).  In addition, compulsive drug taking reduced the motivation 
towards, and salience of alternative goals or stimuli (Cuddy 2004, 
London et al 2000), thereby narrowing the behavioural repertoire 
exhibited in experienced drug users.  These features of compulsive drug-
taking have lead to speculation that alterations in the processing of drug-
associated stimuli may increase the incentive-motivational properties of 
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stimuli associated with a substance, thereby causing ‘craving’ or 
‘wanting’, leading to compulsive drug use (Leshner & Koob 1999, 
Robinson & Berridge 1993; 2000; 2001; 2003).  
Evidence for alterations in the processing of drug stimuli has been 
derived from the widely reported persistence in cue reactivity to drug 
related stimuli in current and former drug abusers.  For example, the 
presentation of exteroceptive drug associated stimuli produced increased 
motivation for drug consumption in humans (Carter & Tiffany 1999, 
Childress et al 1986, Ehrman et al 1992, Ehrman et al 1990, See 2002).  
Users of crack cocaine distinguished cues experimentally paired with 
cocaine consumption, based on their physiological and psychological 
response to these stimuli (Childress et al 1993, Foltin & Haney 2000).  
The ability of drug-associated stimuli to elicit a state of craving has been 
demonstrated in cocaine (Childress et al 1993, Ehrman et al 1991, 
Ehrman et al 1992, Harris et al 2004, Risinger et al 2005), heroin- 
(Childress et al 1986, Franken et al 2004), nicotine- (Hutchison et al 
2004) and alcohol- (Drummond et al 1990) abstinent abusers.  In 
populations of intravenous drug users, conditioning is so profound that 
the phenomenon of ‘needle freaking’ is reported, whereby drug users will 
maintain drug-taking behaviours in the absence of a drug, injecting a 
vehicle solution (Pert 1994, Pert et al 1990).   
 In laboratory animals, the ability for situational cues to elicit a 
response similar to a drug-induced response after repeated pairings with a 
given substance, has been noted since 1927, when apomorphine 
associated cues elicited a physiological response in the absence of 
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apomorphine (Pavlov, 1927; cited in(Pert et al 1990).  The potential 
involvement of Pavlovian conditioning as an underlying mechanism in 
drug addiction was subsequently ignored until the 1960’s, when 
conditioned locomotor responses were established after treatment with 
methamphetamine (Irwin & Armstrong, 1961). The development of 
conditioned responses has since been found following repeated 
administration of amphetamine (Gold et al 1988, Pickens & Crowder 
1967, Tilson & Rech 1973), methamphetamine (Irwin & Armstrong, 
1961), cocaine (Barr et al 1983, Hinson & Poulos 1981, Kalivas et al 
1998, Post et al 1976) and morphine (Hinson & Siegel 1983, Kamat et al 
1974).  These conditioned response include locomotor activation, 
rotational behaviour, cataleptic effects, and avoidance behaviours 
(Blakenship et al, 2000; Cassas et al, 1988; Cervo & Samanin, 1996; 
Chinen & Frussa-Filo, 1999; Pert et al 1990).  These findings suggest that 
alteration in the processing of drug associated stimuli occurred after 
repeated exposure to commonly abused substances.  
Conditioned place preference (CPP) studies have also demonstrated 
that the repeated pairing of neutral stimuli with drug stimuli will produce 
a conditioned response when the neutral stimulus alone is presented.  In 
CPP paradigms, an animal is typically pre-treated with a drug in a distinct 
environment, and subsequent preference, as measured by either increased 
time or locomotor activity, for the drug treated environment and an 
alternative environment is measured (Tzschentke et al 2002, Tzschentke 
et al 2006).  CPP studies have demonstrated that repeated exposure to 
cocaine (Brown & Fibiger 1993, Calcagnetti et al 1995, de Wit & Stewart 
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1983, Hemby et al 1994, Kosten & Nestler 1994, Phillips & Fibiger 1990, 
Ziedonis & Kosten 1991), morphine (de Wit & Stewart 1983, Duarte et al 
2003, Vezina & Stewart 1987, Vezina & Stewart 1987, Wang et al 2003), 
amphetamine (Campbell & Spear 1999, Pucilowski et al 1995, Schildein 
et al 1998, Swerdlow & Koob 1984, Tran-Nguyen et al 1998), ethanol 
(Itzhak & Martin 2000, Rochester & Kirchner 1999) and nicotine (Dewey 
et al 1999, Le Foll & Goldberg 2005, Le Foll et al 2005, Spina et al 
2006), produced a preference for the drug associated environment.   In 
addition, many DA agonists have also facilitated CPP, including 
apomorphine (Parker 1992), quinpirole (Hoffman et al 1988), 
bromocriptine (Hoffman et al 1988), 7-OH-DPAT (Kling-Petersen et al 
1995), while DA receptor antagonists attenuated cocaine- (Calcagnetti et 
al 1995), amphetamine- (Bardo et al 1999), methamphetamine- (Suzuki 
& Misawa 1995), and morphine- (Suzuki & Misawa 1995) produced 
CPP, thus, conditioned reinforcing effects appear to dopaminergically 
mediated.   
Several different lines of evidence from self-administration studies 
have indicated that stimuli associated with drug taking behaviours are 
important components in the maintenance of drug self-administration.  
Discriminative stimuli have been used in many self-administration studies 
to facilitate and maintain drug taking of commonly abused substances 
such as cocaine (Balster et al 1992, Balster & Schuster 1973, Goldberg & 
Gardner 1981, Weiss et al 2003), amphetamine (Davis & Smith 1976, Di 
Ciano et al 2001), and morphine (Davis & Smith 1976).  For example, 
repeated selective presentation of stimuli prior to cocaine availability 
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subsequently maintained responding in the absence of cocaine (Panlilio et 
al 1996, Weiss et al 2001, Weiss et al 2003).  Furthermore, presentation 
of drug-associated stimuli produced a rapid dopaminergic response 
immediately prior to responding in the absence of self-administered 
substances (Carelli & Ijames 2000, Phillips et al 2003).  The 
discriminative ability of drug-associated stimuli to indicate the onset or 
availability of self-administration is hypothesised to result in drug- taking 
behaviours being controlled by these associated stimuli (Beninger et al 
1989, Foltin & Haney 2000). More complex discriminative stimuli 
studies have further demonstrated that stimuli associated with drug 
reinforcement can maintain responding.  For example, some studies use 
multiple stimuli, typically a light and tone, to indicate the availability of 
drug reinforcement (Panlilio et al 1996, Panlilio et al 2000).  The additive 
summation of discrete discriminative stimuli has been demonstrated to 
reliably increase responding maintained by cocaine and heroin at a 
greater magnitude than drug stimuli alone, or single discriminative 
stimuli (Panlilio et al 1996, Panlilio et al 2000). 
 Stimuli previously associated with drug self-administration also 
reinstated extinguished self-administration (Crombag & Shaham 2002; 
De Vries et al 2001; Deroche-Gamonet et al 2003; Di Ciano et al 2003; 
Fuchs et al 2004; Grimm et al 2002; McFarland & Ettenberg 1997; See 
2002; Tran-Nguyen et al 1998; Weiss et al 2001b).  This cue induced 
reinstatement persisted after both short and long extinction periods 
(Arroyo et al 1998, Meil & See 1996).  The ability for drug associated 
stimuli to produce responding after self-administration behaviour has 
MDMA Self-administration     - 36 - 
 - 36 - 
been extinguished further supports the hypothesis that drug associated 
stimuli acquired some properties of the reinforcing substance, and that 
presentation lead to drug seeking.     
Second-order schedules have also been used to evaluate the influence 
of drug -associated stimuli on responding.  Second-order schedules are 
defined as a behavioural sequence  that is created by schedule, as a single 
unit, in turn reinforced by another schedule of reinforcement (Kelleher 
1966).  Animals respond for the presentation of conditioned reinforcer 
commonly on a fixed  ratio or fixed interval schedule.  The presentation 
of the conditioned stimuli then initiates a second schedule controlling 
delivery of the unconditioned stimulus (Goldberg & Gardner 1981, 
Goldberg et al 1975, Kelleher 1966).  Goldberg (1973) published the first 
study to systematically look at drug self-administration under second-
order schedules.  Using squirrel monkeys, animals were maintained on a 
FR30 or FR10 schedule of cocaine, or d-amphetamine delivery, or food 
delivery.  The implementation of a second schedule governing delivery of 
the conditioned stimulus, produced elevated levels of responding prior to 
first delivery of the unconditioned reinforcer, and throughout self-
administration sessions (Goldberg 1973, Goldberg & Gardner 1981).  
Second-order schedules have been shown to maintain high rates of 
responding, due to the intermittent presentation of conditioned stimuli, 
indicating that after significant experience these conditioned stimuli may 
have become conditioned reinforcers capable of maintaining responding 
(Everitt & Robbins 2000, Kelleher 1966).  Accordingly, the removal of 
the conditioned stimulus resulted in a reduction in responding (Arroyo et 
MDMA Self-administration     - 37 - 
 - 37 - 
al 1998, Everitt & Robbins 2000, Goldberg et al 1981, Kelleher 1966).  
The use of second-order schedules was further demonstrated with other 
types of drugs of abuse, including morphine (Goldberg & Tang 1977), 
heroin (Alderson et al 2000), THC (Beardsley et al 1986) and nicotine 
(Dougherty et al 1981).  The development of second-order schedules not 
only provided further evidence that alterations in the processing of drug-
associated stimuli occurred, but also that drug-associated stimuli acquired 
reinforcing properties (Everritt & Robins, 2000).    
Several self-administration studies have evaluated the effects of drug-
associated stimuli on the maintenance on drug self-administration.  
Nicotine self-administration was reported to be susceptible to 
manipulation of a discriminative stimulus and simultaneous conditioned 
stimulus, with reductions in responding noted when either stimulus was  
omitted (Caggiula et al 2002).  The effects of conditioned stimuli on the 
maintenance of cocaine self-administration have been assessed in two 
studies.  The removal of a contingent stimulus light reduced low dose 
cocaine self-administration (Schenk & Partridge 2001), yet in another 
study, removal of the stimulus light had no effect on responding 
maintained by higher cocaine doses (Deroche-Gamonet et al 2002).  
These discrepancies may be due to differences in cocaine acquisition 
doses and duration of stimuli presentation.  Deroche- Gamonet et al 
(2003) used a 2” light presentation with the dose of 1.0mg/kg/infusion 
during acquisition, whereas Schenk & Partridge (2003) presented the 
light stimuli for 12” with the dose of 0.5mg/kg/infusion used during 
acquisition.  The prolonged light exposure may have resulted in the drug-
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associated stimuli having more salience.  While Deroche- Gamonet 
(2002) reported no influence of the light stimulus on the maintenance of 
cocaine self-administration, a decreased acquisition latency was noted 
when cocaine was paired with the light stimulus, indicating that the 
presentation of a previously neutral stimulus may promote the acquisition 
of drug self-administration.   
Conditioned behaviours produced by drugs of abuse are common to 
all abused drugs; however few studies have assessed the conditioning 
properties of MDMA.  One study thus far has assessed the role of a 
MDMA – associated stimulus in the production of a conditioned 
locomotor response.  Animals were pre-treated with MDMA or saline in a 
novel environment with a distinct olfactory stimulus for five consecutive 
days (Gold & Koob 1989).  On the sixth day animals received injections 
of saline and locomotor activity was recorded.  Pre-treatment with 
MDMA produced elevated levels of locomotion when compared to saline 
pre-treatment (Gold & Koob 1989).  CPP after MDMA administration 
has been demonstrated after extended withdrawal periods (Bilsky et al 
1991, Bilsky et al 1990, Horan et al 2000, Marona-Lewicka et al 1996, 
Meyer et al 2002).   
 No self-administration studies have assessed the role of continued 
presentation of a drug-associated stimulus on self-administration 
maintained by MDMA.  However, all published studies purporting 
reliable MDMA self-administration have used a discriminative or co-
incidental light stimulus indicating that the presentation of a conditioned 
stimulus may function in the acquisition and/or maintenance of MDMA 
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self-administration (Lamb& Griffiths et al, Fantegrossi et al 2004; 
Beardsley et al, Lile et al, 2005, Trigio et al 2006).  It is hypothesised that 
like other psychostimulants, MDMA will elicit associative learning, with 
conditioned stimuli acquiring reinforcing properties.  To determine 
whether the continued presentation of an MDMA-associated stimulus has 
an effect on responding maintained by MDMA, animals will be trained to 
self-administer MDMA, and the effect of manipulation of the light 
stimulus, drug stimulus and light and drug stimuli on responding will be 
determined.     
Relapse 
 One final characteristic of drug dependence is the inability of 
drug users to remain abstinent (Chang & Haning 2006, Mendelson & 
Mello 1996, O'Brien et al 1992, Shalev et al 2002).  Resumption of drug 
taking behaviours after a period of abstinence is referred to as relapse.  
Rates of relapse amongst samples of abstinent drug abusers are as high as 
80%, and relapse can occur after prolonged periods of abstinence 
(Childress et al 1988, Hyman & Malenka 2001, Mendelson & Mello 
1996).  Relapse has lead to the suggestion that drug addiction results in 
chronic neuropathology and neuronal adaptation (Chang & Haning 2006, 
Childress et al 1988, Di Chiara 1998, Koob 2006, Robinson & Berridge 
1993).       
 Research with abstinent drug abusers has identified three main 
precipitators of relapse.  Exposure to drug , stress, and drug-associated 
stimuli, have all been suggested to elicit drug craving and subsequently 
the resumption of drug taking behaviours (Childress et al 1986b; 
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Ciccocioppo et al 2001; Drummond et al 2000; Fisher et al 1998; Haney 
et al 1997; Hertling et al 2001; Ingersoll et al 1995; Llorente del Pozo et 
al 1998; Mann et al 1984; Milkman et al 1983; Miller et al 1997; O'Brien 
et al 1998; O'Brien et al 1991; Shaham et al 2003; Spealman et al 1999; 
Stewart 2000; Washton 1988; Weiss et al 2001a; Weiss et al 2001b).  
Exposure to drug-associated paraphernalia and cues elicited strong 
subjective states of craving in cocaine and heroin abusers (Carter & 
Tiffany 1999, Childress et al 1993, See 2002).  Exposure to ‘stressful’ 
images also increased craving, and physiological arousal in abstinent 
cocaine users (Sinha 2001), while exposure to low doses of a previously 
abused substance produced craving and increased drug taking behaviours 
in cocaine abusers (Risinger et al 2005).  Drug abusers distinguish 
between these types of stimuli, however, it is hypothesised that all three 
produce a common introceptive state that leads to drug taking behaviours 
(Carter & Tiffany 1999, Robinson & Berridge 1993, Robinson & 
Berridge 2000, Robinson & Berridge 2001, Robinson & Berridge 2003, 
Sinha 2001).   The development of a relapse model in animals, has 
allowed researchers to explore possible mechanisms underlying relapse.  
  Initially developed by Stretch (1971) on studies using non-human 
primates, and subsequently by de Wit & Stewart (1981) on studies using 
lab rats, the reinstatement paradigm has been extensively utilised to 
explore mechanisms associated with relapse of psychostimulant abuse, 
and to a lesser extent alcohol, nicotine and heroin abuse (Ciccocioppo et 
al 2001; Crombag & Shaham 2002; Epstein et al 2006; Erb et al 1996; 
Katz & Higgins 2003; Shaham et al 2000; Shaham & Hope 2005; 
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Shaham et al 1994; Shaham et al 2003; ShahamY et al 1991; Shalev et al 
2002; Shalev et al 2000; Weiss et al 2001a).   The reinstatement paradigm 
has typically been composed of three phases. In phase one, animals learn 
to reliably self-administer a given substance.  In phase two, the drug is 
substituted for a vehicle solution until responding for the drug stimulus is 
attenuated.  In phase three, animals are exposed to a stimulus and 
reinstatement of responding is measured.  The commonality between 
stimuli associated with relapse in humans and reinstatement in animals 
has lent considerable support to the validity of the reinstatement paradigm 
(Katz & Higgins 2003; Bossert et al 2005, Ciccocioppo et al 2002, Di 
Ciano & Everitt 2002, Grimm et al 2002, Liu & Weiss 2002, See et al 
2003, Shaham et al 2003, Shalev et al 2002), and to the hypothesis that 
common neuronal mechanisms may mediate responses to stimuli that 
produce reinstatement (Kalivas & McFarland 2003).      
Robust drug primed reinstatement of extinguished self-administration 
of a number of drugs including cocaine; heroin, alcohol and nicotine has 
been reported (Shalev et al 2002).  Drug-primed reinstatement increased 
in magnitude with the dose of drug (de Wit & Stewart 1981, Shalev et al 
2002).  Higher doses of a drug prime also produced elevated levels of 
responding maintained for a longer duration (de Wit & Stewart 1981).  It 
may be argued that administration of a drug stimulus, particularly 
psychostimulants produces a general increase in motor activation 
resulting in increased responding.  Analysis of active and inactive lever 
responses, however, has indicated that responding is selective to the lever 
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previously associated with drug self-administration (Shalev et al 2002, 
Stewart 2000). 
Reinstatement produced by drug primes has been attributed to 
dopaminergic mechanisms.  Priming injections of DA agonists, including 
amphetamine, 7-OH-DPAT, GBR 12909 and methylphenidate (Khroyan 
et al 2000, Schenk & Partridge 1999, Self et al 1996, Shaham et al 2003) 
reinstated previously extinguished responding.  Activation of the D2-like 
receptor has been implicated in reinstatement.  The D2-like selective 
agonists, quinpirole and bromocriptine, reinstated responding previously 
maintained by cocaine and heroin (De Vries et al 2002, Wise et al 1990).  
Furthermore, pre-treatment with the D2-like receptor antagonists, 
sulpride, haloperidol and raclopride attenuated reinstatement produced by 
drug primes (Anderson & Pierce 2005, Ettenberg et al 1996, Shaham & 
Stewart 1996).  Pre-treatment with D1-like receptor antagonist, 
SCH23390 attenuated cocaine induced reinstatement (Ciccocioppo et al 
2001, Norman et al 1999), but reports of the effects of D1-like receptor 
agonists have been mixed.  The D1-like agonist, SKF 81297 reinstated 
responding previously maintained by cocaine (Koeltzow & Vezina 2005), 
but another D1-like agonist, SKF 82958 did not reinstate extinguished 
drug-taking behaviour (De Vries et al 1999, Self et al 1996).  
Furthermore, pre-treatment with D1-like agonist attenuated cocaine 
primed reinstatement (Khroyan et al 2000, Self et al 1996).  Thus, 
activation of the D2-like receptors potentiated and  induced drug-primed 
reinstatement, while activation of the D1-like receptor appeared to inhibit 
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reinstatement (Kalivas & McFarland 2003, Khroyan et al 2000, Self et al 
1996, Shaham et al 2003).  
Relapse after MDMA exposure? 
The current status of knowledge regarding MDMA relapse or 
reinstatement is limited.  One longitudinal human study has assessed 
long-term MDMA use and relapse (von Sydow et al 2002).  A small 
proportion of people (0.6% of total sample N=3021), reported difficulty 
abstaining from MDMA consumption; dependence and relapse indicators 
in this sample were stable over time (von Sydow et al 2002), suggesting 
that MDMA may have a relapse potential in a small proportion of people.  
Unfortunately, clinical and retrospective studies have repeatedly omitted 
the systematic assessment of MDMA relapse and associated parameters.   
Preclinical studies have also failed to evaluate the relapse 
potential of MDMA.  No studies have yet evaluated MDMA primed 
reinstatement after extinction of MDMA self-administration.   This 
paucity of knowledge is partially attributable to the limited number of 
laboratories studying MDMA self-administration. One study assessing 
the effects of MDMA administration on the reinstatement of prior 
amphetamine self-administration reported that MDMA reinstated 
responding previously maintained by amphetamine in animals that had 
been pre-treated with MDMA, but not in animals without prior MDMA 
experience (Morley et al 2004), suggesting that MDMA can induce 
reinstatement after prior MDMA exposure.  
Determination of the relapse potential of MDMA is an important 
and novel contribution to the MDMA literature.   Assessments of MDMA 
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primed reinstatement can be used to further clarify the abuse potential of 
MDMA and to further understand mechanisms governing MDMA use.  A 
determination of whether responding previously maintained by MDMA, 
can be reinstated with DA agonists can provide information regarding the 
neural mechanisms underlying repeated MDMA use.  Furthermore, the 
demonstration of DA primed reinstatement would lend support to the 
hypothesis of a common neurobiological mechanism underlying 
reinstatement, and relapse.  A simple evaluation of whether MDMA can 
prime responding after extinction of self-administration behaviours will 
be assessed using a reinstatement paradigm.   
     
Aims 
In summary, the aim of this thesis is to determine if MDMA is a 
reinforcer of responding, and to explore some of the basic parameters of 
MDMA self-administration.  Four fundamental features of self-
administration will be assessed.  Firstly, the reliability of MDMA self-
administration will be determined using a variety of self-administration 
techniques.   Secondly, the role of DA in the maintenance of MDMA 
self-administration will be evaluated.  Thirdly, the development of 
conditioned responding after MDMA self-administration will be 
evaluated.  Finally, the ability for MDMA administration to elicit 
reinstatement of responding previously maintained by MDMA will be 
assessed.       
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Chapter 2 - Method 
Subjects 
Subjects were male, Sprague Dawley rats bred in the vivarium at 
Victoria University of Wellington. Rats were housed in hanging 
polycarbonate cages in groups of 4-6 until they reached weights of 200-
250gm (locomotion experiments) or 300-325 gm (self-administration 
experiments). Thereafter, they were separated and housed in isolation. 
The animal colony was temperature- (21 ° C) and humidity- (74%) 
controlled, and food and water were available ad libitum except during 
testing. The colony was maintained on a 12:12-h light/dark cycle with 
lights on at 0700. All procedures were in accord with OLAW regulations 
(USA) and were approved by the Animal Ethics Committee of Victoria 
University of Wellington. 
 
Surgery for self-administration studies: 
Rats in the self-administration experiments were implanted with 
an indwelling silastic catheter in the right jugular vein.  Animals received 
atropine (1.0mg/kg; IP) 30 minutes prior to anesthesia. The rats were 
deeply anesthetized with ketamine (60.0 mg/kg, IP; Kelburn Vet Centre, 
Wellington, New Zealand) and sodium pentobarbital (20.0 mg/kg, IP; 
Kelburn Vet Centre, Wellington, New Zealand). The external jugular vein 
was isolated, the catheter was inserted and the distal end (22 ga stainless 
steel tubing) was passed subcutaneously to an exposed portion of the 
skull where it was fixed to embedded jeweler's screws with dental acrylic.  
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Each day, the catheters were infused with 0.1 ml of a sterile saline 
solution containing heparin (30.0 U/ml; Kelburn Vet Centre, Wellington, 
New Zealand), Penicillin G sodium (250,000 U/ml Kelburn Vet Centre, 
Wellington, New Zealand) and streptokinase (8000/ml Kelburn Vet 
Centre, Wellington) to prevent infection and the formation of clots.  The 
rats were allowed five days post-surgery for recovery prior to behavioral 
testing.  
Apparatus  
 
Self-administration 
Self-administration training and testing occurred in test chambers 
(Med Associates, ENV 001; Vermont, USA) enclosed in sound 
attenuating closets. The testing room containing the 32 test chambers was 
humidity- (74%) and temperature- (21 ° C) controlled. Each chamber was 
equipped with 2 levers and a stimulus light. Depression of one lever (the 
active lever) resulted in an infusion of drug. Depression of the other lever 
(the inactive lever) was without programmed consequence. Infusions 
were in a volume of 0.1 ml delivered over 12.0 sec via Razel pumps 
equipped with 1.0 rpm motors and 20.0 ml syringes. Coincident with each 
infusion was the illumination of a stimulus light located above the active 
lever.  
 
LocomotionEight Open field chambers (Med Associates; 
Vermont, USA) equipped with banks of 16 photocells on each wall were 
used to measure horizontal locomotion.  The open field boxes were 
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interfaced with a computer and data were obtained using Med Associates 
software. Each activity chamber was enclosed in a sound attenuating box 
(Med associates; Vermont USA).  As the animal moved around the 
chamber, broken light beams were counted.     
All testing was conducted during the light cycle between 1000 and 
1600 hours.  A red house light was illuminated during testing and white 
noise was also continually present to mask extraneous disturbances.   
 
General Self-administration Procedures 
Unless otherwise stated, each session began with an experimenter-
administered infusion of MDMA or cocaine.  Thereafter, infusions were 
delivered according to an FR-1 schedule of reinforcement by depression 
of the active lever.  Depressions on the inactive lever were recorded but 
had no programmed consequence.  Self-administration was considered 
acquired when during a session (1) at least 7 active lever responses were 
produced, and (2) the ratio of active: inactive lever responses was at least 
2:1.  When these criteria were met for at least three consecutive days with 
less than 20% variation in active lever responses across days, the drug 
dose was halved.  Training continued until there was less than 20% 
variability in the number of responses produced across three consecutive 
testing days. 
Drugs 
For self-administration studies, racemic MDMA HCL (ESR Ltd, 
Porirua, New Zealand) and cocaine HCL (Merek Pharmaceuticals. 
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Palmerston North, New Zealand) were dissolved in sterile 3u /heparinzed 
saline (0.9%NaCl). For locomotor activity studies, racemic MDMA was 
dissolved in saline (0.9% NaCl). MDMA purity was examined by gas 
chromatography/mass spectrometry and NMR, and assessed at greater 
than 98%. Intravenous infusions were delivered in a volume of 0.1 ml and 
intraperitoneal injections were delivered in a volume of 1.0 ml/kg. 
SCH 23390 (NIDA, USA), eticlopride (SIGMA; Australia), SKF 
81297 (Tocris, Natick, Massachusetts) were dissolved in 0.9% saline.  
Subcutaneous (SC) or Intraperitoneal (IP) injections were in a volume of 
1 ml/kg. All drug doses refer to the salt.  
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Chapter 3- Experiment 1 
Acquisition and maintenance of MDMA self-administration 
 
 The aim of the first experiment was to determine if MDMA can 
function as a behavioural reinforcer .   A substitution procedure was  
used, as other published studies have reported MDMA self-administration 
under this procedure (Beardsley et al 1986, Fantegrossi et al 2002, 
Fantegrossi 2002, Lamb & Griffiths 1987, Ratzenboeck et al 2001).  
Factors involved in the maintenance and acquisition of MDMA self-
administration were  will also determined.     
Method 
Procedures  
Acquisition of MDMA self-administration in either drug naïve 
rats (n=11), or animals that had received cocaine self-administration 
training (0.5 mg/kg/infusion; 5-12 daily 2-h tests; N=5) was assessed.  
Drug naïve rats received 26 daily tests.  MDMA (1.0 mg/kg/infusion) was 
available for self-administration during daily 2-h (n=5) or 6-h (n=6) 
sessions for 11 days.  Most responses were recorded in the initial hour of 
testing and there was no difference in responding as a function of test 
duration.  Therefore data obtained from the 11 initial self-administration 
days for both groups were combined.  Animals that had received 6-h 
sessions were run for a further 8 daily 6-h sessions with the dose of 
0.5mg/kg/infusion MDMA available.  The test session was then reduced 
to 2-h duration and saline was substituted for MDMA during the next two 
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test days.  This was followed by 5 days of 2-h tests during which the dose 
of 0.5mg/kg/infusion was again available.  Rats (n=5) first trained with 
cocaine self-administration (0.5mg/kg/infusion; FR1; 8-12 days) received 
subsequent 6-h tests of MDMA self-administration (1.0mg/kg/infusion).   
 
Eight rats received additional tests to further examine the dose 
dependant nature of responding maintained by MDMA.  For these tests, 
different doses of MDMA (0.25-2.0mg/kg/infusion) were available 
during daily 2-h sessions.  The starting dose for MDMA self-
administration was 2.0mg/kg/infusion and the dose was reduced by half 
every two successive sessions.  Data from the second day of each dose 
were used for analyses.  A final additional test measured responding 
maintained by MDMA (1.0mg/kg/infusion) during a 24-h test (n=5).  For 
these tests, the test chambers were equipped with a water bottle and food 
tray.      
To further determine whether MDMA reliably reinforced operant 
responding, animals (n=12, 3/per triad) were yoked and operant response 
rates were assessed for rats that received contingent MDMA, non-
contingent MDMA, or vehicle.  In each triad, one animal responded 
contingently for MDMA (1.0mg/kg/infusion), the second animal received 
a non-contingent infusion of MDMA based on the behaviour of the 
contingent rat, while the third animal received non-contingent saline 
based on the behaviour of the contingent rat.  All animals were run for 20 
days in daily 2-h sessions.  No prior training had occurred for any 
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animals, and all subjects were drug naïve prior to beginning the 
experiment.  Due to technical difficulties one animal in the non-
contingent MDMA group had to be removed from the study, therefore 
final group numbers were; contingent MDMA (n=4), non-contingent 
MDMA (n=3), non-contingent saline (n=4).                 
In order to establish whether MDMA self-administration was 
sensitive to schedule manipulation (see Table 1), a group of drug naïve 
animals (n=12) was trained to self-administer 1.0mg/kg/infusion MDMA 
during daily 6-hr sessions under an FR1 schedule.  The dose was then 
reduced to 0.5 mg/kg/infusion.  Once the number of responses showed 
less than 20% variability over three consecutive days, the schedule was 
then increased to FR2 and finally FR5. MDMA was then replaced with 
vehicle solution and the light stimulus was removed during the next two 
self-administration sessions.  Thereafter, responding was reinforced with 
MDMA (0.5mg/kg/infusion) and the light stimulus, according to an FR-5 
schedule of reinforcement.   
MDMA dose 
(mg/kg/infusion) 
1.0 0.5 0.5 0.5 saline 0.5 
FR schedule FR1 FR1 FR2 FR5 FR1 FR5 
Table 1: Procedure for schedule manipulation 
 
A final of group of animals (n=6) was trained to self-administer 
MDMA as above.  Following training the schedule was then changed to a 
progressive ratio schedule.   Under this schedule, the first response 
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produced an infusion of MDMA (0.5 mg/kg/infusion), thereafter the FR 
requirements increased by FR8 for each successive reinforcer.  The 
session concluded after one hour had elapsed since the last ratio 
completion.  The “break point” was defined as the last ratio completed.  
The total number of infusions was also recorded.  The initial dose 
available was 0.5mg/kg/infusion MDMA, and then the dose was changed 
to 0.25mg/kg/infusion or 1.0mg/kg/infusion.  Rats were tested with at 
least two doses of MDMA and two animals received three doses.  Final 
group number for each dose were 0.5mg/kg/infusion (n=5), 
0.25mg/kg/infusion (n=4), 1.0mg/kg/infusion (n=4)        
Data Analysis: 
Data from self-administration experiments were subjected to a 
two-way between  measure ANOVA (days X pre-exposure condition).  
Dose dependant responding was analysed using a two- way repeated 
measure ANOVA (dose X lever).  To compare contingent MDMA, non-
contingent MDMA and saline response rates in yoked animals, a 2-way 
repeated measures ANOVA (Day x Group) was performed. Schedule 
dependent responding were analyzed using repeated measures ANOVA 
to compare the number of responses produced on the “Active” lever for 
each day.  For the progressive ratio experiments, break points, as defined 
by the highest number of response recorded for a single infusion of 
MDMA were measured averaged over three days for each dose that a 
subject self-administered.   
All post-hoc analyses were performed using paired-samples t-tests 
(within-subject design), tukey’s (between subject designs) or simple 
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contrasts (repeated measures).  Results were deemed significant at a level 
of p<0.05. 
Results 
Figure 1 shows responding maintained by MDMA for rats that 
were initially drug naïve.  Responding on the inactive lever remained low 
throughout the 26 days of testing.  During the first 6 days of testing when 
1.0mg/kg/infusion MDMA was available, responding on both the inactive 
and active lever remained low.  Between days 7-11, responding 
maintained by 1.0mg/kg/infusion MDMA increased and a preference for 
the active lever developed ( F (1, 11) =5.844, p<0.039).  When the dose 
of MDMA was reduced by half to 0.5mg/kg/infusion between days 12-
19, responding on the active lever increased further over days, (F (7, 30) 
=2.859, p<0.022), and a preference for the active lever was demonstrated 
(F (1, 5) = 9.375, p<0.038).  Saline substitution on days 20-21 produced a 
reduction in responding when compared to the two prior self-
administration sessions  (F(3,12) = 4.449, p<0.025), and responding was 
reinstated when MDMA was made available on days 22-26 (F(3,12)= 
5.162, p<0.016). 
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Figure 1.  From Schenk et al (2003): Acquisition of MDMA self-
administration by drug naïve rats.  Mean response (+SEM) on the active 
and inactive levers are presented as a function of day of testing and dose 
of MDMA.  
 
Figure 2 compares active and inactive lever responding 
maintained by MDMA (1.0mg/kg/infusion) during the initial six 6-h daily 
tests for animals that were drug-naive and animals that had  prior cocaine 
self-administration experience.  Active lever responding of cocaine-
trained rats was significantly higher (F(1,8)=5.137, p<0.05) when 
compared to drug –naïve animals. 
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Figure 2.  From Schenk et al (2003): Acquisition of MDMA self-
administration for animals that had received either cocaine self-
administration (n=4), or drug naïve animals (n=6).  Mean responses 
(+SEM) on the active lever and inactive levers are presented as a function 
of day of testing. 
 
Figure 3 shows responding as a function of MDMA dose. 
Decreasing the dose of MDMA produced an increase in responding 
(F(4,12)= 9.767, p<0.01).  Post hoc simple contrasts revealed that 
responding maintained by 2.0mg/kg/infusion was significantly lower than 
that maintained by 1.0mg/kg/infusion (p<0.049), 0.5mg/kg/infusion 
(p<0.029) and 0.25mg/kg/infusion (p<0.003).  No difference was found 
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between responding maintained by saline and 2.0mg/kg/infusion MDMA 
(p=0.06).     
Figure 3. From Schenk et al (2003): Responding maintained by different 
doses of MDMA (n=5).  Symbols represent the mean number of 
responses (+SEM) during daily 2 hour sessions. 
 
Figure 4 shows the pattern of responding during each 2-h daily 
self-administration for a representative rat.  Higher doses of MDMA were 
self-administered primarily during the first 30min of each session.  Self-
administration of the lower dose of MDMA (0.25mg/kg/infusion) 
produced persistent responding throughout the session.  The number of 
infusions maintained by saline was comparable to the number of 
infusions maintained by the higher doses of MDMA; however, 
responding maintained by 2.0mgkg/infusion MDMA was elevated in the 
first hour and then reduced in the second hour.  Responding maintained 
by saline was sporadic throughout the session.   
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Figure 4. From Schenk et al (2003): Temporal pattern of responding 
during a 2-h session maintained by different doses of MDMA for a 
representative rat.  Each vertical dash represents an infusion of MDMA 
 
Figure 5 shows the average number of active lever responses 
produced during each hour of the 24-h session.  One of the eight animals 
died after 11.5 hours.  During the initial hour, responding was elevated 
(figure 5; insert) and during the subsequent hours responding was reduced 
and stable at 2-4 responses per hour.  For one animal responding was 
increased in the 20th hour.    
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Figure 5.  From Schenk et al (2003): temporal pattern of responding 
maintained by 1.0mg/kg/infusion during a 24-h self-administration 
session.  The average number of responses (+SEM) during each hour of 
the test is shown.  One animal died after approximately 11.5h of self-
administration.  The insert shows the average number of responses 
(+SEM) during each 10-min interval of the first hour of testing. 
 
 
MDMA self-administration was acquired in animals receiving 
MDMA infusions and co-incidental light presentation, contingent on 
lever depression (figure 6).  In comparison, animals receiving non-
contingent MDMA or saline demonstrated low levels of responding on 
both the active and inactive lever. The average number of MDMA 
infusions (0.5mg/kg/infusion) received by contingent and non-contingent 
animals was 268.5 (SEM=49.97) during the 20 days of testing.  Repeated 
measures analyses revealed a significant interaction between self-
administration days and  lever, and group (F(38,152)=2.574, p<0.001).   
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A significant difference between groups was found (F(2,8)=8.985, 
p<0.009), with post-hoc analyses revealing differences between 
contingent and non-contingent MDMA groups (p<0.007).  In addition, an 
interaction between day and group was revealed (F(38,152) = 2.057, 
p<0.001).  Post hoc simple contrasts revealed differences from contingent 
MDMA (p<0.05), for both non-contingent saline and non-contingent 
MDMA.  
Days
0 2 4 6 8 10 12 14 16 18 20 22
R
e
sp
o
n
se
s 
o
n
 
a
ct
iv
e
 
le
ve
r
0
5
10
15
20
25
30
35
con MDMA 
yoked MDMA
saline 
b
a
a
a
a
a
a a
a
a
a
a
b
b
b
b
b
b
b
b
a
Condition
 
Figure 6. Responding on the active lever by animals receiving, 1) 
contingent MDMA infusions, 2) non-contingent MDMA infusions, and 
3) non-contingent saline infusions.  
Lower case letters a) Denotes significant differences in responding on the 
active lever between animals receiving non-contingent and contingent 
MDMA,  b) Denotes significant differences in responding in animals 
receiving contingent MDMA and non-contingent saline.  
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Figure 7 shows that responding on the inactive and active levers 
varied as function of group (F(2,8)=7.639, p<0.014).  Subsequent within-
subject repeated measures analyses for each group revealed a preference 
for the active lever for animals receiving contingent MDMA 
(F(1,3)=4.557, p<0.032), whereas non-contingent MDMA and non-
contingent saline failed to show a lever preference (p=0.276, p=0.072 
respectively). 
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Figure 7. Symbols represent the mean active and inactive lever responses 
per day (+SEM) for each group; Contingent MDMA, non-contingent 
MDMA, non-contingent saline.    
 
MDMA Self-administration     - 62 - 
 - 62 - 
Figure 8 shows active lever responding on (1) the last day of 
testing under the various schedules of reinforcement (FR1, FR2, and 
FR5), (2) the two days when saline was substituted for MDMA and (3) 
the day when MDMA and the light stimulus were reintroduced as 
reinforcers of operant responding (FR5).  Responding increased as FR 
value increased, decreased when MDMA and the light stimulus were 
removed and was reinstated to a comparable level when MDMA and the 
light stimulus were again available to reinforce operant responding 
(F(5,55)=24.172, p<0.001). Post hoc simple contrasts revealed no 
difference between baseline FR5 responding and re-initiation FR5 
responding, or between saline days.   
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Figure 8. From Daniela et al (2006):  Effects of increasing 
demand (FR1, FR2, FR5) and saline substitution on MDMA self-
administration. Symbols represent the mean number of responses per 2 hr 
session (+ SEM).Figure 9 shows responding maintained on a progressive 
ratio schedule of reinforcement.  Breakpoint, and the number of infusions 
self-administered increased as the dose of MDMA available was 
increased (breakpoint (F(2,10)=7.0321, p<0.012), number of infusions 
(F(2,10) = 7.032, p<0.012)).  Responding as a function of dose 
approached significance (p<0.053).  Post-hoc analysis revealed a 
significant difference between 0.25mg/kg/infusion MDMA and 
1.0mg/kg/infusions for both breakpoint (p<0.01) and number of infusions 
received (p<0.01).       
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Figure 9. Number of infusions and breakpoints maintained under a 
progressive ratio schedule of reinforcement.  Symbols represent the mean 
number (+/- SEM) of responses, breakpoint and infusion totals received, 
for each dose of MDMA. * denotes significant difference from 
0.25mg/kg/infusion MDMA 
 
Summary 
MDMA was reliably self-administered.  MDMA was self-
administered by drug naïve and cocaine- trained animals, but those with 
prior cocaine self-administration experience acquired MDMA self-
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administration with decreased latencies.  A preference for the active lever 
was produced only when drug delivery was dependent on lever 
depressions.  Rats that received non-contingent MDMA or vehicle 
injections failed to demonstrate a preference for the active lever.  MDMA 
self-administration was dose dependent, when either FR or PR schedules 
were imposed.  Responding for MDMA increased as the FR ratio was 
increased, decreased when MDMA was substituted for a vehicle solution, 
and then increased when MDMA was reintroduced.  MDMA self-
administration was demonstrated to be sensitive to demand, as measured 
by a progressive ratio schedule of reinforcement.   Under the current 
parameters, MDMA reliably reinforced responding, and was self-
administered by animals under a variety of conditions.   
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Chapter 4- Experiment 2 
Role of Dopamine in MDMA self-administration 
 
The aim of the second experiment was to determine if MDMA 
self-administration wass sensitive to dopaminergic manipulation.  The 
activation of dopaminergic substrates is a common feature to all drugs of 
abuse (Carelli 2004; Carr et al 1988; Di Chiara 1999; Di Chiara et al 
2004; Fibiger et al 1992; Koob & Hubner 1988; Koob & Weiss 1990; 
Pulvirenti & Koob 1990; Ranaldi et al 1999; Robinson & Berridge 1993; 
2000; Sahakyan & Kelley 2002; Salamone & Correa 2002; Wise 1984; 
1987; 1998; Wise & Bozarth 1982; 1985; Wise et al 1995b; Wolf 2002).   
In order to obtain effective dose and pre-treatment times to be used in 
subsequent self-administration experiments, preliminary tests on the 
effects of the D1-like antagonist SCH23390, and the D2-like antagonist 
eticlopride, on the locomotor activating effects of MDMA were 
conducted.  Thereafter, these doses were  used in self-administration 
experiments.      
Method - locomotion studies 
Procedure 
Locomotion 
Prior studies conducted in our lab have demonstrated that 
20mg/kg MDMA produced maximal locomotor response (Brennan et al, 
2006).  Accordingly, the present study examined the effects of SCH 
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23390 and eticlopride on hyperactivity produced by 20.00 mg/kg 
MDMA.  
 Separate groups of rats (n=6) were injected with SCH 23390 
(0.01-0.08 mg/kg; SC), eticlopride (0.125- 1.0 mg/kg; IP) or the saline 
vehicle and were immediately placed in the activity boxes. After a 15- 
(SCH 23390) or 30- (eticlopride) min pre-treatment period, they received 
an injection of MDMA (20mg/kg; IP) and activity counts were measured 
for an additional 60 min.   
In order to determine whether SCH23390 or eticlopride altered 
basal levels of activity, the lowest doses of SCH23390 (0.02mg/kg) or 
eticlopride (0.05mg/kg) that produced an effect on MDMA- induced 
hyperactivity were administered to animals that received saline.  Animals 
(n=8/per group) were placed into the activity chambers and received 
immediate injections of either saline or SCH23390 (0.02mg/kg; n=8) 
saline/eticlopride (0.05mg/kg; n=8) or saline/saline (n=8).  Activity 
counts were recorded every 5 minutes for 60 minutes.   
Data Analysis 
Activity data were analyzed using repeated measures ANOVA 
(Antagonist dose X Time).  Post hoc tukey tests were then performed to 
determine direction and variables of significance.   
 
Results - locomotion studies 
 Figure 10 shows the effect of SCH 23390 on MDMA-produced 
hyperactivity as a function of dose and time.  The insert shows the total 
counts during the 60 min period following the MDMA injection for 
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groups that received various doses of the antagonist. SCH 23390 
produced a dose-dependant decrease in MDMA-produced hyperactivity 
(F (4,16) = 4.274, p<0.05).  Post-hoc analyses revealed that decreases 
produced by doses equal to or greater than 0.02 mg/kg SCH23390 were 
significant (p<0.05). The interaction between dose and time was also 
significant (F(44, 253) =2.457, p<0.001) and post-hoc analyses revealed 
that the decreases were produced primarily during the first 30 min 
following the injection of MDMA (p<0.05).   
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Figure 10. From Daniela et al (2004). Effect of SCH23390 (0.00mg/kg – 
0.08mg/kg) on locomotor activity produced by MDMA (20mg/kg) 
administration.  SCH23390 was injected at time -15min and MDMA was 
injected at time 0 min.  Symbols represent the mean number of activity 
counts (+/- SEM) as a function of SCH23390 dose and time. Lower case 
MDMA Self-administration     - 69 - 
 - 69 - 
letters denote significant decrease (p<0.05) from 0.0mg/kg SCH23390.  
Insert: total activity counts produced by each group during the 60 min 
period following MDMA injection.    
 
 
Figure 11 shows the effect of SCH 23390 (0.02 mg/kg) or the 
saline vehicle on baseline activity levels. For both groups, activity levels 
are initially high and decrease progressively throughout the session. 
Activity levels of the SCH 23390 group were comparable to activity 
levels of the control group and there was no significant decrease as a 
result of antagonist treatment (F(1,14)=0.105, NS). 
 
 
 
Figure 11. From Daniela et al (2004). Effects of SCH23390 (0.02mg/kg) 
on baseline locomotor activity. SCH23390 or the saline vehicle was 
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administered at time 0.   Symbols represent the mean activity count (+ 
SEM).  
 
Figure 12 shows the effect of eticlopride on MDMA-induced 
hyperactivity as a function of time. MDMA-induced locomotor activity 
was dose dependently reduced by eticlopride (F (4, 16) = 5.345, p<0.01).  
In addition, eticlopride dose dependently increased the latency to 
MDMA- induced hyperactivity (F(11,264)= 18.686, p<0.001). Significant 
decreases were produced by eticlopride doses greater than 0.025 mg/kg 
(p<0.05).  The effects were apparent 20 min following the MDMA 
injection and persisted throughout the 60 min test.  
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Figure 12. Effects of eticlopride (0.0mg/kg- 0.1mg/kg) on MDMA-
induced (20mg/kg) locomotor activity. Eticlopride was injected at time -
30 min and MDMA was injected at time 0 min. Symbols represent the 
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mean number of activity counts (+/-SEM) as a function of eticlopride 
dose and time. Lower case letters denote significant difference from 
0.0mg/kg eticlopride. Insert: total activity counts produced by each group 
during the 60mins following MDMA injection.   
 
Figure 13 shows the effect of eticlopride (0.05 mg/kg) or the 
saline vehicle on baseline activity levels. For both groups, activity levels 
are initially high and decrease progressively throughout the session. 
Activity levels of the eticlopride group were comparable to activity levels 
of the control group and there was no significant decrease as a result of 
antagonist treatment (F(1,14)=0.178, NS). 
 
Time (min)
0 10 20 30 40 50 60 70
Ac
tiv
ity
 
Co
u
n
ts
0
50
100
150
200
250
300
Eticlopride 
Saline
 
Figure 13.  Figure 2 Effects of eticlopride (0.02mg/kg) on baseline 
locomotor activity. Eticlopride or the saline vehicle was administered at 
time 0.   Symbols represent the mean activity count (+ SEM).  
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Method - self-administration 
Procedure 
Self-administration 
Drug naive animals were trained to self-administer MDMA and 
responding was stabilized.  Tests were conducted to assess the effect of 
SCH23390 (0.02 mg/kg, SC) or eticlopride (0.05mg/kg, IP) on 
responding maintained by a range of MDMA (0.25-2.0 mg/kg/infusion) 
doses.  These doses were chosen based on the results of the hyperactivity 
tests since they produced minimal effects on baseline activity but 
attenuated MDMA-produced hyperactivity.  
A recurring series of tests comprised of baseline and test days was 
used. At least two days of baseline testing were interspersed between tests 
of the antagonist effect. Antagonists were administered only when there 
were at least two prior and consecutive baseline tests during which the 
number of responses did not vary by more than 20%.  
Initially, the dose of MDMA available for self-administration was 
0.5 mg/kg/infusion.  Once the effect of SCH 23390 or eticlopride on 
responding maintained by this dose of MDMA was measured, the 
MDMA dose was either increased or decreased for individual subjects 
and the effect of the antagonist on responding maintained by this new 
dose of MDMA was assessed. Data for all doses of MDMA were 
obtained for some of the rats (n=4) but for others tests of the effects of 
antagonists on responding maintained by a subset of the doses of MDMA 
were obtained (n=6). Final group numbers were; 0.25 mg/kg/infusion 
(n=7), 0.5mg/kg/infusion (n=8), 1.0mg/kg (n=7), 2.0mg/kg/infusions 
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(n=7).  The effects of eticlopride (0.05mg/kg) on responding maintained 
by 0.25-2.0mg/kg/infusion MDMA were assessed in one group of 
animals (n=4).    
Further tests were also conducted on separate groups of rats to 
assess the effects of various doses of SCH23390 (0.02-0.005mg/kg) on 
responding maintained by 0.5 (n =5), 1.0 (n=4) and 2.0mg/kg MDMA 
(n=4).  Effects of eticlopride (0.05-0.125mg/kg) on responding 
maintained by 1.0mg/kg/infusion were also measured (n=6/group). 
Data Analysis 
The effects of SCH23390 on MDMA self-administration data 
were determined using an ANOVA (Dose).  Eticlopride self-
administration data were analysed using a repeated measures ANOVA 
(dose eticlopride X MDMA dose).  Post-hoc t-tests were subsequently 
performed to determine change between baseline and antagonist 
treatment for each dose.  Baseline data were obtained from the last self-
administration day prior to antagonist pre-treatment.  
 
Results - self-administration 
 
Figure 14 shows the effect of SCH23390 (0.02 mg/kg) on 
responding maintained by a range of self-administered MDMA doses. 
MDMA-reinforced responding decreased as MDMA dose increased (F 
(3, 25) = 12.959, p<0.005).   Responding maintained by 
0.25mg/kg/infusion MDMA was elevated significantly when compared to 
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responding maintained by 2.0mg/kg/infusion (p<0.05) and 
1.0mg/kg/infusion (p<0.05).  Furthermore, responding maintained by 
0.5mg/kg/infusion was also elevated when compared to 
2.0mg/kg/infusion MDMA (p<0.013).  SCH23390 (0.2mg/kg) produced a 
rightward shift in the MDMA dose-effect curve. ANOVA revealed a 
significant interaction between MDMA and SCH 23390 dose (F (3, 25) = 
8.234, p<0.001).  Paired-sample t-tests revealed that responding 
maintained by 0.25mg/kg/infusion MDMA was attenuated by SCH23390 
(t(6)= 4.494, p<0.004) whereas responding maintained by 1.0 
(t(6)=2.509, p<0.049) and 2.0 (t(6)= 4.264, p<0.005) mg/kg/infusion 
MDMA was increased by SCH23390.  
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Figure 14.  From Daniela et al, (2004). Dose dependant responding 
maintained by MDMA self-administration (0.25-2.0mg/kg/infusion; filled 
circles) and responding maintained by MDMA after SCH23390 
(0.02mg/kg; empty circles) administration.  Symbols represent the mean 
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number of responses (+/-SEM).  * indicates significant difference 
(P<0.05) from baseline levels of responding. 
 
Figure 15 shows the effects of SCH23390 (0.005mg/kg- 
0.02mg/kg) on responding maintained by 2.0mg/kg/infusion MDMA.  
Responding increased after pre-treatment with 0.01mg/kg SCH23390 (F 
(1, 3) = 10.206, p<0.05) and 0.02mg/kg SCH23390 (F (1, 3) = 10.947, 
p<0.045). The effects of 0.005-0.02mg/kg SCH23390 on responding 
maintained by 0.5 mg/kg/infusion and 1.0mg/kg/infusion MDMA failed 
to reveal any significant interaction (p=0.375, p= 0.208).   
SCH23390 dose (mg/kg)
R
e
sp
o
n
se
s 
on
 
th
e 
a
ct
iv
e
 
le
ve
r
0
5
10
15
20
25
30
MDMA baseline
SCH23390 
0.005 0.01 0.02
*
*
 
Figure 15. Effects of different doses of SCH23390 (0.005-0.02mg/kg) on 
responding maintained by 2.0mg/kg/infusion MDMA.  Symbols represent 
the mean number of responses (+/- SEM).  * indicates significant 
(p<0.05) increase from baseline responding. 
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Responding maintained by MDMA (0.25-2.0mg/kg/infusion) was 
also dose dependant (F(3,9)=34.202, p<0.001) in animals receiving 
eticlopride pre-treatment (Figure 16).  Analyses, however, failed to reveal 
a significant interaction between MDMA dose and eticlopride treatment 
(p=.817).  Responding was not altered by changes in eticlopride dose (p = 
0.093).   
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Figure 16.  Dose dependant responding maintained by MDMA self-
administration (0.25-2.0mg/kg/infusion; filled circles) and responding 
maintained by MDMA after eticlopride (0.05mg/kg; empty circles) 
administration.  Symbols represent the mean number of responses (+/-
SEM).   
 
SummaryMDMA self-administration was sensitive to 
dopaminergic manipulations. MDMA produced dose-dependant increases 
in basal locomotor activity.  SCH23390 and eticlopride dose-dependently 
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decreased MDMA –induced locomotor activity.  SCH23390 shifted the 
dose response curve for MDMA self-administration to the right, 
decreasing responding at low doses and increasing responding at high 
doses.  Eticlopride pre-treatment failed to shift the dose effect curve; 
however, responding for the higher doses of MDMA increased.  
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Chapter 5- Experiment 3 
Influence of conditioned stimuli on MDMA self-administration 
 
 The aim of the third experiment was to determine if MDMA self-
administration produces conditioned responding.  The transition from 
drug use to abuse is hypothesised to involve alterations in the processing 
of drug-associate stimuli (Leshner & Koob 1999, Robinson & Berridge 
1993; 2000; 2001; 2003; Childress et al 1988, Childress et al 1986, 
Ehrman et al 1990, Haney et al 1999, O'Brien et al 1992, O'Brien et al 
1992, Robinson & Berridge 1993).  The effects of manipulation of the 
light and/or drug stimuli on responding were  be measured.   
Method 
Procedure 
A new group of rats were trained to self-administer MDMA 
(1.0mg/kg/infusion) as described above. Once 75 (+/- 5) infusions (range 
for meeting this criterion was 5-15 days) had been self-administered, the 
MDMA dose was reduced to 0.5 mg/kg/infusion for a further 150 (+/-10) 
infusions (range for meeting this criterion was 6-19 days).  Responses per 
day and the number of days to criterion were recorded for each animal.  
This phase of self-administration training lasted an average of 19.2 days 
during which rats self-administered approximately 225 infusions of 
MDMA associated with a light stimulus. 
The rats were then divided into groups (n=6/gp) to test the 
influence of the continued contingent presentation of the light stimulus or 
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the drug stimulus on operant responding. One group continued to receive 
a drug infusion (0.5 mg/kg/infusion) according to an FR1 schedule of 
reinforcement but the light stimulus that had been associated with drug 
infusions was omitted (DRUG ONLY group). Another group continued 
to receive the light stimulus that had been paired with self-administered 
drug infusions but the MDMA was replaced with the 3 U heparin/ml 
saline vehicle solution (LIGHT ONLY group). A final group received 
only vehicle solution, without the light stimulus (NO LIGHT/NO DRUG 
group). These conditions were maintained during an additional 15 daily 2 
hr sessions. Total responses per session and temporal pattern of 
responding within each session were recorded for all subjects.  A group 
of unoperated drug-naïve rats (n=7) was tested to determine whether the 
light stimulus was a reinforcer of operant responding when it had not 
been paired with MDMA infusions (NO DRUG/LIGHT).  These rats 
were placed in the operant chambers for  daily 2 hr tests.  Responding on 
the active lever was reinforced by the 12 sec presentation of the light 
stimulus according to an FR1 schedule.      
Data Analysis 
Self-administration data were analysed using separate repeated 
measures ANOVA to examine changes in responding from baseline for 
the LIGHT ONLY, DRUG ONLY, and NO LIGHT/NO DRUG groups.  
The average number of responses produced during the last 5 days of the 
training period served as the baseline number of responses for each rat.  A 
repeated measures ANOVA (Condition X Day) was conducted on the 
number of responses reinforced by the light stimulus only for the group 
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that had previously had the light paired with MDMA infusions (paired 
group) and for the group that had not previously had light/drug pairings 
(unpaired group).  The temporal pattern of responding was summated for 
every ten minute period on baseline day and days 1,5,10,15, of extinction 
for each animal.  Analysis was performed for every ten minute period for 
all groups across extinction days using three wayANOVA (time X 
extinction day X group).  Post hoc tests were performed for days and 
group using tukey pot hoc test, and simple contrast were used to compare 
time periods. 
Results 
Figure 17 shows the average number of responses during baseline 
and on the subsequent 15 days of testing for the LIGHT ONLY, DRUG 
ONLY, NO LIGHT/NO drug groups.  Separate ANOVA for each group 
revealed a significant decrease in responding as a function of days for the 
NO DRUG/ NO LIGHT group (F(15,75) = 4.765, p<0.001) and 
subsequent simple contrasts revealed that the decrease in operant 
responding was significant for all 15 test days (p<0.01).  A decrease in 
responding as a function of days was also observed for the DRUG ONLY 
group (F (15, 75) = 2.380, P<0.01), with simple contrasts showing a 
significant difference from baseline on day 4 and following day 6 of test 
days (p<0.01).  A decrease in responding for the Light ONLY group 
approached significance (F(15, 75)= 1.771, p<0.055) and simple contrasts 
revealed a significant decrease in responding from baseline, on day 6 and 
from day 8 to day 14 (p<0.05).  Baseline responding did not vary between 
groups (F(2,15)= 0.838, p< 0.452). 
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Figure 17.  From Daniela et al, (2006). Effects of removal of light or/and 
drug stimuli on responding over 15 days.  Symbols denote average (+/- 
SEM) daily response rates for baseline responding and extinction 
condition for each condition.  * denotes significant differences from 
baseline responding.    
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Figure 18. Temporal pattern of responding from a representative rat from 
each group, on baseline days 4 and 5, extinction days 1,5,10, 15.  Each 
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vertical bar denotes a depression on the active lever.  Despite individual 
variation, analyses revealed all groups to have comparable time course;  
 
 
Figure 18 shows the temporal pattern of responding a 
representative rat from each group, on two baseline days, and extinction 
days 1, 5, 10, 15.  Analyses revealed that all groups demonstrated the 
typical elevated responding in the first ten minutes followed by a 
reduction and low levels of responding throughout the session for all 
extinction days (F(11,616)= 39.691, p<0.001).  No difference between 
extinction days was found (p=0.594).    Figure 19 shows the average 
number of responses over the 4 extinction days (1,5,10,15) for each 
group.   Responding maintained by either the light or drug stimuli 
produced elevated levels of responding through the session when 
compared to the No light, No drug group (F (22,616) = 3.237, p<0.001).       
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Figure 19.  The average number of responses on the active lever every ten 
minutes for each group.  Data averaged over extinction days 1,5,10, 15.  
Symbols denote (=/-SEM) average responses every ten minutes over 120 
minutes.  
 
Figure 20 shows the average number of responses when lever 
presses were reinforced by presentation of the light stimulus only.  Data 
are from rats that had experienced the light stimulus paired with self-
administered MDMA and for a group of drug naïve animals that had not 
experienced the light stimulus in any context.  Responding maintained by 
the presentation of the light stimulus was higher for the group that had 
received prior MDMA/light pairings (F(1,11)=36.733, p<0.01), and 
subsequent simple contrasts revealed that the differences were significant 
across all days.  
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Figure 20.  From Daniela et al, (2006).  Effects of prior drug – light 
pairing on responding maintained by the presentation of a light stimulus.  
Symbols represent the average number of responses (+/-SEM) on the 
active lever for animals with prior MDMA self-administration experience 
(filled circles) and drug naïve animals (empty triangles). * denotes 
significant (p<0.01) group differences 
Summary 
 
Manipulation of the light and/or drug stimuli produced changes in 
self-administration behaviors.  Removal of both stimuli dramatically 
reduced responding, while removal of the light produced a trend towards 
a reduction in responding, indicating that the light stimuli may have 
acquired conditioned reinforcing properties.       
Chapter 6 – Experiment 4 
Reinstatement of responding previously maintained by MDMA 
 
 The aim of the fourth experiment was to determine if MDMA 
administration will reinstate responding previously maintained by 
MDMA.  Relapse after abstinence from abused substances is a common 
feature of addiction (Chang & Haning 2006, Mendelson & Mello 1996, 
O'Brien et al 1992, Shalev et al 2002).  MDMA doses were  administered 
to animals after a period of extinction, and responses  were measured.   
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Method 
Procedure 
Rats were trained to self-administer MDMA using the procedure 
described in the general methods. Reinstatement of MDMA self-
administration was assessed in a group of animals (N=8).  However due 
to catheter patency, 3 animals did not complete this study.    Following 
the acquisition, the schedule of reinforcement was increased to FR2.  
After stable responding (less than 20% variation over three consecutive 
days) was produced, the schedule of reinforcement was increased to FR5 
and responding stabilised.   
A recurring series of 6 hr daily tests comprised of baseline, 
extinction and reinstatement phases was conducted.  Phase one consisted 
of at least two days of responding that was reinforced by an infusion of 
MDMA (FR5, 0.5 mg/kg/infusion) with the associated light stimulus. 
During Phase two (minimum two days), the MDMA solution was 
replaced with vehicle and the light stimulus that had been paired with 
self-administered MDMA infusions was omitted. These conditions were 
imposed for a minimum of two days and continued until there were less 
than 30 responses produced.  At the start of phase three, rats received an 
injection of MDMA (0.0 – 10.0 mg/kg, IP). During these tests, 
responding continued to be reinforced by an infusion of vehicle and the 
light stimulus was illuminated according to an FR5 schedule of 
reinforcement.  Drug seeking behaviour was defined as the number of 
responses on the active lever during phase three.   Order of MDMA dose 
was randomised between animals, and no repetition effect was found.    
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Data Analysis 
The responses from reinstatement days were analysed using a 
within subjects repeated measures ANOVA.   Temporal responding from 
reinstatement data was also analysed using a between  measures ANOVA 
for each hour of reinstatement (hrs X group).   
Results 
 
Figure 21 shows the average number of responses on the active 
lever for all animals during MDMA administration, extinction, and 
MDMA reinstatement doses. ANOVAs conducted for baseline and 
extinction days revealed no significant difference across baseline days 
(P>0.28) or extinction days (P>0.5).  In contrast, a main effect for 
MDMA reinstatement dose was observed (F(2,8) = 14.573, p<0.05).  
Contrasts indicated that responding was significantly increased for the 
MDMA doses 5mg/kg (F(1,4) = 33.5534, p<0.05) and 10mg/kg (F(1,4) = 
15.76, p< 0.05) compared to 0.0mg/kg MDMA.     
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Figure 21.  Effect of experimenter administered MDMA (0.0-10mg/kg) 
on responding in animals previously trained to self-administer MDMA.  
Bars denote number of depressions on active lever during testing phases. 
* denotes significant difference from 0.00mg/kg MDMA.    
 
Figure 22 shows the temporal pattern of responding on the active 
lever during each hour of reinstatement.  Responding during the 6 hour 
reinstatement phase varied as a function of MDMA dose (F (10, 60) = 
4.400, p<0.005).  Post hoc simple contrasts revealed that responding 
produced by 10mg/kg MDMA maintained elevated levels of responding 
when compared to 0.0mg/kg (p<0.005) and 5mg/kg (p<0.002).  No 
difference in the temporal pattern of responding was found between 
0.0mg/kg and 5mg/kg MDMA (p=0.463).  Responding produced by 
10mg/kg MDMA was elevated during the first three hours of responding 
(p<0.05).     
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Figure 22.  Effects of experimenter administered MDMA (0.0-10mg/kg) 
on responding previously maintained by MDMA.  Symbols represent the 
mean (+/-SEM) responses as function of hour. 
Summary 
MDMA self-administration could also be reinstated after 
extinction of responding resulting from removal of the drug and light 
stimuli.  Experimenter administration dose dependently increased 
responding on the active lever in the absence of self-administered 
MDMA.   
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Chapter 7- Discussion 
 
 The aim of the current thesis was to examine factors involved in the 
acquisition and maintenance of MDMA self-administration.  MDMA was 
demonstrated to be reliably self-administered in drug-naïve and cocaine-
trained animals.  Responding was contingent to the active lever, reduced 
with vehicle substitution, sensitive to dose and schedule manipulation, 
and increased as demand increased.  MDMA self-administration was also 
sensitive to dopaminergic manipulation.  Pretreatment with SCH23390 
produced a rightward shift in the dose response curve.  Removal of the 
light and drug stimuli produced a rapid reduction in responding.  In 
contrast, responding was reduced slowly when either the light or drug 
stimuli were removed, suggesting that the light and drug stimuli appeared 
to have comparable abilities to reinforce responding in animals with 
MDMA self-administration histories.  Responding was also reinstated 
when animals previously experienced with MDMA self-administration 
were administered MDMA.  The demonstration of reliable self-
administration and subsequent determination of factors involved in 
MDMA self-administration is a novel contribution to the literature on 
MDMA, and has provided extensive support to the suggestion that 
MDMA may have abuse liability (see Schenk et al, 2003, Daniela et al, 
2004; Daniela et al, 2006).     
Reliable MDMA self-administration 
 Previous studies have indicated that MDMA self-administration 
is readily produced in laboratory animals that had a prior history of 
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cocaine self-administration (Beardsley et al 1986, Fantegrossi et al 2002, 
Fantegrossi 2002, Lamb & Griffiths 1987, Ratzenboeck et al 2001).  In 
the present study, rats experienced with cocaine self-administration also 
readily acquired MDMA self-administration suggesting that prior 
exposure to cocaine may have sensitized animals to the reinforcing 
effects of MDMA.  A wealth of studies have indicated that pretreatment 
with psychostimulants sensitizes rats to the behavioral effects of 
subsequent injections (Kalivas & Stewart 1991, Robinson & Becker 
1986), while latency to acquisition by untrained drug naïve animals was 
delayed.  Latency to acquisition of self-administration was decreased by 
pretreating rats with either the to-be self-administered drug or a variety of 
other drugs (Schenk & Gittings 2003, Schenk & Izenwasser 2002, Schenk 
& Partridge 1997, Schenk & Partridge 2000). Previous studies have 
indicated that some of the behavioral effects of MDMA are susceptible to 
sensitization. For example, acute exposure to MDMA resulted in 
locomotor activation that became sensitized following repeated exposures 
(Kalivas et al 1998, McCreary et al 1999, Spanos & Yamamoto 1989). 
Cross sensitization has also been demonstrated and rats that received 
treatment with MDMA became more responsive to the locomotor 
activating effects of amphetamine (Callaway & Geyer 1992), and cocaine 
(Kalivas et al 1998) as well as to the conditioned reinforcing effects of 
cocaine (Horan et al 2000). Of interest, rats that were pretreated with 
MDMA subsequently acquired self-administration of a low dose of 
cocaine with shorter latencies than rats that received saline pretreatment 
(Fletcher et al 2001).  Consistent with these studies, the present results 
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indicate that neuronal mechanism common to both cocaine and MDMA 
may be mediating self-administration.  
MDMA self-administration was gradually acquired with repeated 
daily tests in rats that had no prior self-administration training and were 
drug naïve. These data are comparable to data obtained when the 
acquisition of self-administration of other psychostimulant drugs was 
measured. Acquisition of cocaine (Schenk et al 1991, Schenk & Partridge 
2000, Schenk et al 1993) and amphetamine (Carroll & Lac 1997, Piazza 
et al 1989, Pierre & Vezina 1997) self-administration occurred gradually 
over days.  The gradual increase in the average number of responses as a 
function of test day resulted from the recruitment of subjects that reliably 
self-administered the drug over days.  
  Following acquisition, responding maintained by MDMA was 
dose-dependent, extinguished when saline was substituted for the drug 
and was reinstated when MDMA was reintroduced.  The number of 
responses was an inverse function of MDMA dose. These results were 
comparable to those produced in early psychostimulant self-
administration studies (Gotestam & Andersson 1975, Hoffmeister & 
Goldberg 1973, Smith et al 1976, Yokel & Pickens 1973, Yokel & Wise 
1978).  There was almost perfect compensatory responding that 
maintained drug intake at about 18-20 mg/kg during daily sessions.  It has 
been suggested that changes in operant responding as function of dose are 
due to titration of drug effects (Hurd et al 1989, Neisewander et al 1996, 
Pettit & Justice 1989, Pettit & Justice 1991, Ranaldi et al 1999, Wise et al 
1995, Wise et al 1995).  Therefore, the dose dependant responding 
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demonstrated suggests that animals were actively titrating the effects of 
MDMA.   
The relatively high dose of MDMA consumed in the current study 
is somewhat disparate to the doses typically consumed by humans (de la 
Garza et al, 2006).  The average dose of MDMA in a MDMA pill varies 
considerably, and is estimated to be between 80 -150mg (Lesiter et al, 
1992; Siegal et al, 1986; Parrott & Lasky, 1998).    De la Garza et al 
(2006) reported that the mean consumption of MDMA in humans is 
1.8mg/kg per session.   In novice MDMA users, a single pill is consumed, 
however, heavy MDMA users typically show a pattern of maintenance 
dosing throughout an evening, and as previously mention can consume 10 
or more pills in an evening (Winstock et al, 2001).  
In the current experiments, animals that acquired MDMA self-
administration consumed approximately 17-25mg/kg MDMA per day.  
While this appears to be a significant variation, it may not be, as animals 
were only included when they acquired MDMA self-administrations.  
Animals that did not meet acquisition criteria were excluded.  It is 
possible that the results reported are more consistent with heavy MDMA 
use in humans, rather than  mean MDMA consumption.  An alternative 
explanation is that variation across species is to be expected, due to 
physiological factors such as speed of metabolism.  Research into the 
neurotoxic effects of MDMA on serotonin neurons lead to the use of 
inter-species scaling for drug doses (Ricaurte et al, 2000).  Due to smaller 
body mass and rapid drug clearance in rodents, equivalent drug doses in 
rodents are significantly higher than mg/kg doses used by humans.  
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Ricaurte et al (2000) argue that the dose of 20mg/kg in a rodent is 
equivalent to 1.28mg/kg in humans.  This dose is comparable to the dose 
of MDMA self-administered in the present studies.      
The demonstration of reliable, dose-dependent self-administration 
is consistent with characteristics of a drug that possesses high abuse 
liability (Ator & Griffiths 2003, Kozikowski et al 2003). This 
interpretation is strengthened by the finding that reliable self-
administration persisted during a single 24 hr session. MDMA self-
administration during this long session differed however, from what has 
previously been reported for cocaine self-administration (Covington & 
Miczek 2005, Mantsch et al 2004, Morgan et al 2002, Mutschler et al 
2001, Schenk & Partridge 1997, Schenk & Partridge 2000). Continuous 
access to cocaine self-administration produced binge patterns of 
consumption, characterized by an initial ‘loading up’ phase and 
‘regulatory’ phase (Tornatzky & Miczek 2000).  During the regulatory 
phase, responding maintained by cocaine infusions persisted at a high 
hourly rate throughout the self-administration session (Mantsch & 
Goeders 2000, Mutschler et al 2001, Roberts et al 2002, Schenk et al 
2001, Tornatzky & Miczek 2000).  The pattern of temporal responding 
maintained by MDMA was characterized by an initial ‘loading up’ phase 
and then a prominent reduction in responding with periodic responses on 
the active lever at a low hourly rate.  This may be due to the long duration 
of action of MDMA and/or the accumulation of an active metabolite.  
3,4-methylenedioxyamphetamine (MDA), a major metabolite of MDMA 
is known to increase extracellular levels of serotonin and dopamine (Nash 
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& Nichols, 1991; Schmidt et al, 1987).  It is possible that the increases in 
MDA after initial MDMA administration, may maintain elevated levels 
of dopamine over a prolonged duration of time decreasing the need for 
‘top up’ responses.  Furthermore, the secondary dopamine release that 
occurs as a consequence of 5-HT1B and 5-HT2A receptor activation may 
also prolong elevations in dopamine levels (Lucas & Spampinato, 2004).  
If animals are titrating the effects of MDMA through responses, then it 
would be expected that these mechanisms would reduce responding, as 
dopamine levels remain elevated.  A methodology employing 
microdialysis would provide a more comprehensive answer to these 
suggestions.       
 When saline was substituted for MDMA after experience with MDMA 
self-administration, responding decreased for these more experienced 
rats. Saline-maintained responding was, however, higher than had been 
observed during acquisition and a preference for the active lever was 
demonstrated during these saline-reinforced trials. These findings suggest 
that these rats with an extensive history of MDMA use were more 
resistant to extinction than animals with limited MDMA self-
administration experience.  Of note, in this study, the light stimulus 
remained on, and may have functioned as a conditioned reinforcer 
maintaining responding.   
Operant responding was dependant on contingent administration 
of MDMA, as demonstrated in the yoked experiment.  Animals receiving 
non-contingent light and drug presentation, or non-contingent light and 
vehicle presentations produced low levels of responding on both the 
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active and inactive levers.  Similar findings have been reported with a 
range of substances including, amphetamine (Di Ciano et al 1998, 
Ranaldi et al 1999, Stefanski et al 1999), cocaine (Hooks et al 1994, Meil 
et al 1995, Wilson et al 1994) morphine (Grasing & Miller 1989, 
Mierzejewski et al 2003, Smith et al 1982) and nicotine (Donny et al 
1998).  These results suggest that selective operant behavior was not a 
consequence of the motor-activating effects of MDMA alone, as animals’ 
receiving non-contingent MDMA did not demonstrate elevated 
responding on the active lever.  Furthermore, responding on either lever 
was not maintained by animals that received only non-contingent light 
presentation suggesting that the light stimulus alone failed to have any 
initial effect on self-administration behaviors.  The demonstration of 
elevated levels of responding on the active lever by animals receiving 
contingent MDMA only is a strong demonstration that MDMA self-
administration is a purposeful selective behavior performed by animals.     
 The effects of increasing demand on responding were assessed in two 
experiments.  Initial manipulations demonstrated that an increase in FR 
schedule produced compensatory responding, that responding decreased 
when MDMA and the light stimulus were both removed and was 
reinstated when MDMA and the light stimulus were again made available 
for self-administration.   These results are consistent with those produced 
in primate models (Fantegrossi et al 2002).  The use of an FR schedule of 
reinforcement provided preliminary assessment of reinforcement; this 
schedule, however, did not assess the reinforcing efficacy of a substance 
(Arnold & Roberts, 1997; Richardson & Roberts, 1996).  In the current 
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study, the maintenance of MDMA self-administration was sensitive to 
increasing demand.  The implementation of a PR schedule of 
reinforcement produced an incremental increase in the number of 
infusions received, and breakpoint reached as a function of MDMA dose.  
The dose effect function produced under this condition was consistent 
with those produced by MDMA in the primate (Lile et al, 2004).  The 
demonstration of increasing breakpoints, as MDMA dose increased 
suggests that as MDMA dose was increased, the maximal effort expended 
was also increased – reflective of reinforcing efficacy.    Furthermore, the 
MDMA PR dose effect function produced was comparable to those 
produced in self-administration studies with other commonly abused 
substances (Hubner & Moreton 1991, Loh & Roberts 1990, Risner & 
Goldberg 1983, Roberts 1989, Roberts et al 1989, Szostak et al 1987).  
No direct comparison between MDMA and alternative reinforcers was 
assessed, and as such, the relative reinforcing efficacy of MDMA in the 
rodent is yet to be determined.  Prior studies have indicated that MDMA 
maintained a lower breakpoint, at fewer doses when compared to cocaine 
PR (Lile et al, 2006; Trigio et al, 2006), indicating that MDMA may be a 
less efficacious reinforcer than other psychostimulants.  Future research 
would benefit from comparing the reinforcing efficacy of MDMA and 
other abused substances.    
 While the current thesis has conclusively demonstrated that reliable 
MDMA self-administration can be produced, discrepancies between the 
current findings and other published studies has been raised (see De La 
Garza et al, 2006), leading to speculation that MDMA is not a reliable 
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reinforcer.  Like previous attempts to demonstrate reliable nicotine and ∆-
9- THC self-administration, explanation is likely to be due to 
experimental parameters, rather than the drug itself.  Several major 
differences between other published MDMA self-administration studies 
and the current study are noted.  Firstly, the infusion duration for drug 
delivery in the current study was relatively long at 12 seconds, compared 
to other rodent MDMA self-administration studies.  For example, 
Ratzenboeck et al (2002) reported 6’ infusion duration, while De la Garza 
et al (2006) reported a 4.5’ infusion time.  Increasing the infusion times 
for cocaine self-administration produced a reduction in responding 
(Panlilo et al, 1998; Balster & Schuster, 1973; Samaha & Robinson, 
2005), indicating that infusion duration can affect the acquisition and 
maintenance of self-administration.  In the current study, prolonging the 
infusion time may have had the opposite effect, perhaps due to the 
mechanisms of actions of MDMA.  Initial experiences with MDMA have 
been reported to occasionally be aversive, due to the strong initial 
serotonergic effects (Green et al, 2003).  Prolonging the infusion time and 
exposure to the light stimulus may result in lever depression being 
associated with 5-HT efflux and secondary DA efflux.  The prolonged 
presentation of the light stimulus may have resulted in the light stimulus 
functioning as a predictive stimulus.  Additionally, the volume of infusion 
used was less than those used in other studies.  For example, Ratzenboeck 
et al (2002) reported infusions of 300µl over 6 seconds, compared to the 
100µl over 12 seconds in the current study.  It may be that large infusion 
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volumes of MDMA delivered in rapid infusions produced aversive 
effects.   
Secondly, the absence of a time – out period in the current study 
may have facilitated acquisition of MDMA self-administration, by 
allowing rapid administration of sequential MDMA doses to produce 
maximal effects.  The temporal pattern of responding seen when MDMA 
made available for self- administration, revealed a ‘loading’ phase at the 
beginning of self-administration sessions.  The imposition of a time out 
phase may have reduced this ‘loading’ phase, thereby reducing 
acquisition.   
Thirdly, animals in the current study did not have any prior 
operant training.  Initial exposure to the self-administration environment 
only occurred when MDMA was available for self-administration, 
perhaps strengthening context – dependant learning.  For example, it has 
been reported that associations between specific and contextual 
environmental stimuli and drug administration decreased the acquisition 
latency for other self-administered substances (Arroyo et al 1998, 
Caggiula et al 2002, Smith & Davis 1973).  
Fourthly, acquisition of MDMA self-administration occurred 
during relatively long self-administration sessions.  For example, De La 
Garza et al (2006) reported 3 hr daily sessions, in contrast to the 6hr daily 
sessions used currently.  Previous studies have shown that longer access 
times to cocaine and amphetamine increased responding, and drug intake 
(Ahmed & Koob 1999, Mantsch et al 2003, Mantsch et al 2004).  While 
this factor may increase acquisition, some animals were trained during 
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daily two hour sessions, indicating that session duration alone did not 
determine acquisition.  Of note, animals trained during two hour sessions 
tended to have a longer acquisition periods, than those trained in 6 hour 
sessions.  Systematic analysis of the effects of session duration on 
MDMA acquisition latency would determine if this observation has any 
significance.   
The demonstration of MDMA self-administration in the current 
study may be due to some of these experimental conditions.   It may also 
be due to other unqualified factors.  For example, in the current study, all 
animals received a ‘priming’ injection of MDMA at the being of each 
acquisition session.  This daily exposure to MDMA may have gradually 
sensitised animals to the effects of MDMA.  Other published rodent 
MDMA studies do not report on priming, therefore comparisons are 
difficult.  In order to determine the factors that assisted in MDMA self-
administration, a methodical assessment of all the potential factors 
contributing to the acquisition of MDMA self-administration is required.  
 The first experiment of this thesis demonstrated reliable MDMA self-
administration.  Acquisition of MDMA self-administration was 
demonstrated in both drug naive and cocaine trained animals, whereas 
animals receiving non-contingent MDMA did not perform selective 
operant behaviour.  Animals responded in a dose dependant manner, 
ceased when MDMA was replaced with vehicle solution, and was 
reinstated when MDMA was made available again. Furthermore, 
increasing the demand required for reinforcement produced schedule 
dependant increases in responding.  These findings are novel 
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contributions (Schenk et al 2003) to understanding the mechanisms 
underlying MDMA use.  The demonstration of MDMA self-
administration provides a robust animal paradigm for further research 
into factors affecting MDMA consumption.   The relative absence of 
published studies demonstrating MDMA self-administration and 
attempting to characterise psychopharmacology mechanisms underlying 
MDMA reinforcement may be due to conceptualisation of MDMA as a 5-
HT agonist and potential neurotoxic substance (Bankson & Cunningham 
2001, Battaglia & De Souza 1989, Cole & Sumnall 2003, Green et al 
1995, Green et al 2003, Parrott 2002, Shulgin 1986).  The concern over 
MDMA neurotoxicity has lead research to focus primarily on causes, 
modulators and protective factors – pharmacological and environmental 
for MDMA neurotoxicity.  Given the wealth of evidence demonstrating 
toxicity, further investigation into the behavioural features of MDMA 
consumption is necessary in order to prevent and treat the effects of 
MDMA induced neurotoxicity.   
Dopaminergic mechanisms in MDMA self-administration 
The second experiment examined the role of dopamine in the 
behavioural effects of MDMA.  MDMA –induced locomotion and self-
administration was reduced with dopamine receptor antagonism. MDMA-
produced hyperactivity was attenuated in a dose-dependent manner by 
pre-treatment with SCH 23390 and eticlopride at doses lower than those 
producing general disruption of motor activity (Millan et al, 2001; Meyer 
et al, 1993; Piggins & Merali, 1989).  These findings contribute to the 
hypothesis that dopaminergic mechanisms underlie MDMA-produced 
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hyperactivity (Ball et al 2003, Bubar et al 2004, Fernandez et al 2003, 
Gold et al 1989).  Furthermore, these findings are consistent with 
microdialysis and electrophysiology studies that have shown MDMA 
induced dopamine elevations. For example, administration of MDMA 
(10mg/kg) elevated locomotor activity levels and increased extracellular 
DA in the nucleus accumbens of Fisher rats (Fernandez et al 2003), while 
MDMA administration (5mg/kg) also resulted in elevated locomotor 
behaviour and excitation of neurons in the striatum (Ball et al 2003).  
SCH233390 (0.2mg/kg) delayed the locomotor activating effects of 
MDMA and excitation of striatal neurons, while eticlopride (0.2mg/kg) 
administration attenuated MDMA –induced locomotion and neuronal 
excitation (Ball et al 2003). The reduction in MDMA –induced 
locomotion seen after dopamine antagonism was also comparable to 
studies reporting DA antagonism of the locomotor activating effects of 
amphetamine and cocaine (Gold et al 1989, Kelley & Lang 1989, Piazza 
et al 1991, Wallace et al 1996).                        
The role of dopamine in the reinforcing effects of common 
psychostimulants has been demonstrated through the production of 
rightward shifts in the dose response curves.  SCH23390 pre-treatment 
resulted in rightward shifts in the dose-response curve for self-
administration of cocaine (Caine 1995, Caine & Koob 1994, Carelli & 
Deadwyler 1996, Corrigall & Coen 1991, Maldonado et al 1993) and 
amphetamine (Barrett et al 2004, Beninger et al 1989, Phillips et al 1994, 
Sziraki et al 1998).  Antagonism of the D2-like receptors also shifted the 
dose response curves for cocaine and amphetamine self-administration in 
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a rightward direction(Barrett et al 2004, Bergman et al 1990, Caine & 
Koob 1994, Hemby et al 1996, Schenk & Gittings 2003).   
In the current study, pre-treatment with SCH 23390 produced a 
rightward shift in the dose-effect curve for MDMA self-administration. In 
contrast, dose dependant MDMA self-administration was not 
significantly altered by eticlopride pre-treatment, although increases in 
responding were noted after eticlopride pre-treatment when the two 
highest doses of MDMA were made available for self-administration.   
The production of a rightward shift in dose-response curves is 
consistent with a pharmacological blockade (Barrett et al 2004, Caine & 
Koob 1994, Hubner & Moreton 1991, Koob et al 1987).  The shift in 
dose-response function has been attributed to variations in the 
neurological substrates involved and drug-receptor interactions (Kenakin, 
1993).  For example, the behavioral consequences of drug consumption 
may be due to the density of available receptors or the affinity for a 
receptor by a specific substance (Kenakin, 1993).  Higher densities of 
available receptors would suggest an increased response to a low unit of 
drug, whereas, a drug with low affinity for available receptors would 
require a higher unit dose to order to achieve a maximal effect.  It is 
likely that the increased responding evident after SCH23390 pretreatment 
was due to receptor blockade, therefore limiting available D1-like 
receptors requiring increased drug –intake to maintain comparable 
reinforcing effects.   
Administration of eticlopride, a D2-like antagonist, surprisingly, 
failed to have any significant effect on an MDMA produced dose 
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response curve.  Pre-treatment with haloperidol – a widely use D2-lke 
receptor antagonist blocked the subjective effects of positive mood and 
‘mania’ produced by MDMA in humans (Liechti & Vollenweider 2000).  
While explanation may be found in the physiological differences between 
humans and rodents, or the discrepancies between operant responding and 
subjective experiences, a more likely explanation is that it is due to the 
experimental parameters of the current study.  Eticlopride pre-treatment 
did increase responding at higher MDMA doses, but had no effect on 
responding maintained by low doses of self-administered MDMA.   The 
within subject design utilized was a rigorous assessment of D2 –like 
receptor involvement, however, high variability and small sample size 
may have been causal factors in the absence of an effect.  Therefore, 
theoretical interpretation of these results may be premature.  Further 
assessment of the role of the D2-like receptor in MDMA self-
administration is required before any valid interpretation can be made.       
Though MDMA has behavioural activating effects consistent with 
other psychostimulants, the role of serotonin is less well clarified. 
Serotonin neurons innervate dopaminergic systems that underlie the 
reinforcing effects of drugs of abuse (Herve et al., 1987). Evidence is 
emerging that activation of some serotonin receptor subtypes facilitates 
dopamine effects (Bankson & Cunningham 2001, De Deurwaerdere 
1999, De Deurwaerdere et al 2004, Di Giovanni 1999, Lucas et al 2000, 
McCreary et al 1999, Schmidt et al 1994, Yan 2000, Yan & Yan 2001).   
The acute elevations in 5-HT and subsequent activation of 5-HT post-
synaptic receptors are implicated in the locomotor activating effects of 
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MDMA.  For example, antagonism of the 5-HT1B and 5-HT2A receptors 
reduced MDMA induced locomotion, where as antagonism of the 5-
HT2C increased MDMA induced locomotion (Bankson 2002, Bankson & 
Cunningham 2001, Fletcher et al 2002, McCreary et al 1999).  
Antagonism of the 5-HT1B and 5-HT2A reduced MDMA-produced 
dopamine increases (Lucas & Spampinato 2000, Schmidt et al 1994).  
Therefore, it is likely that change in locomotor behaviour seen after 
serotonergic pre-treatment’s are due to interactions with dopaminergic 
systems.  For example, antagonism of the 5-HT2A receptor attenuated 
MDMA induced excitation of striatal neurons and locomotion while SB 
206553, a 5-HT2C/2B antagonist had no effect on either MDMA induced 
locomotion or neuronal response to MDMA (Ball & Rebec 2005).   
Serotonergic mechanisms have also been implicated in the 
reinforcing effects of MDMA.  Pretreatment with the 5-HT2 antagonist 
ketanserin, decreased MDMA self-administration by rhesus monkeys 
without altering cocaine self-administration (Fantegrossi et al 2002).  
Though no study has thus far determined whether the reported 
interactions between the serotonin and dopamine systems are applicable 
to self-administration studies, it is likely that the same mechanisms are 
activated by both self-administered MDMA and experimenter 
administered MDMA.   Repeated MDMA-produced increases in 
serotonin might also repeatedly activate reward-relevant dopaminergic 
substrates. This repeated activation of dopamine might be expected to 
lead to neurochemical sensitization that becomes expressed in reliable 
self-administration. This effect of repeated MDMA would also explain its 
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ability to enhance the reinforcing and other behavioral effects of cocaine 
(Fletcher et al 2001, Horan et al 2000)(Fletcher et al., 2001; Horan et al., 
2000; Kalivas et al., 1998), which has been attributed to sensitization of 
dopaminergic substrates. 
During self-administration training and testing, rats received 
substantial exposure to MDMA.  Repeated exposure to MDMA produces 
effects on brain chemistry that might play a role in the ability of MDMA 
to increase synaptic dopamine and produce positively reinforcing effects 
that maintain self-administration.  
It is well-documented that exposure to MDMA produces toxicity 
in central serotonergic systems (Battaglia et al 1988, Reneman et al 2001, 
Reneman et al 2006, Ricaurte et al 2000, Schmidt et al 1990). There are 
complex interactions between serotonin and dopamine but several studies 
have shown that self-administration of cocaine (Czoty et al 2002, Fletcher 
et al 2002, Loh & Roberts 1990), morphine (Dworkin et al 1988) and 
amphetamine (Leccese & Lyness 1984) was altered following serotonin 
depletion, presumably as a result of decreased serotonin modulation of 
dopamine. It has also been reported that exposure to MDMA produced a 
persistent decrease in the density of 5-HT2c receptors (McGregor et al 
2003). This might also contribute to the ability of MDMA to increase 
synaptic dopamine since activation of 5-HT2c receptors decreased 
dopamine release (Blackburn et al 2002, Di Giovanni et al 2002, Filip & 
Cunningham 2003). Following acute MDMA administration increases in 
5-HT and the resulting activation of 5-HT2c receptors (Gudelsky & 
Yamamoto 2003) might be expected to limit MDMA-produced increased 
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dopamine.  For example, Ramos et al (2005) reported attenuation of 
MDMA sensitization after administration of the 5-HT2c receptor agonist, 
MK-212, indicating a likely role for the 5-HT2c receptor in MDMA –
induced behaviour.   
Following repeated exposure, however, this inhibitory effect 
might be less influential because of decreased 5-HT2c receptor densities.  
The resulting disinhibition would contribute to  the sensitized dopamine 
response produced following repeated MDMA exposures (Kalivas et al 
1998). This sensitized neurochemical response would be expected to 
maintain MDMA self-administration and produce cross-sensitization in 
the behavioural effects of MDMA and other indirect dopamine agonists 
(Callaway & Geyer 1992, Cole et al 2003, Fletcher et al 2001, Itzhak et al 
2003, Kalivas et al 1998).  
In summary, MDMA locomotion and self-administration was 
demonstrated to be sensitive to blockade of the D1-like receptor.  
Blockade of the D2-like receptor dose dependently reduced MDMA 
induced locomotion, but had limited effects on MDMA self-
administration.  These findings are the first to demonstrate that the 
reinforcing effects of MDMA are dependant on dopaminergic activation 
(see Daniela et al 2004).  Furthermore, the production of rightward shift 
in the MDMA dose-response curve after DA antagonism indicates that 
similar pharmacological mechanisms underlie the reinforcing properties 
of MDMA and other commonly abused substances.   
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Maintenance of responding by MDMA- associated stimulus 
The third experiment evaluated the role of the drug and /or drug-
associated light stimulus on responding.  For rats that had extensive 
experience with MDMA self-administration removal of both the drug and 
the light stimulus that had been paired with intravenous drug infusions 
led to a dramatic and rapid decrease in operant responding. When operant 
responding continued to produce either the light stimulus or the drug 
infusion, the decrease in responding was delayed relative to when both 
stimuli were omitted. Thus, the light stimulus that had been paired with 
self-administered MDMA infusions was sufficient to reinforce 
responding for several days even in the absence of the MDMA infusion. 
Similarly, MDMA infusions were sufficient to maintain responding for 
several days once the drug-associated light stimulus had been removed. 
When either the drug or the light stimulus was removed however, 
responding eventually decreased to rates that were comparable to when 
both the drug and the light were removed. Because the light stimulus 
failed to reinforce responding for the group that had not received 
light/drug pairings, these data suggest that the light stimulus had acquired 
reinforcing properties through repeated pairings with self-administered 
MDMA infusions.  
Previous studies have documented rapid extinction of self-
administration of a number of drugs of abuse (DiCiano & Everritt 2004; 
Grimm et al. 2002; Neiswander et al. 1996; See et al. 1999) and 
presentation of drug-associated stimuli reinstated extinguished cocaine- 
(Deroche- Gamonent et al. 2003; Di Ciano et al. 2004) and 
methamphetamine- (Anggadiredja et al. 2004) taking behavior. In another 
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study (Schenk and Partridge 2001), the continued presentation of a light 
stimulus that had been associated with self-administered cocaine 
infusions was required for the maintenance of high rates of cocaine self-
administration; removal of the stimulus that had been associated with 
self-administered cocaine resulted in a dramatic decrease in operant 
responding despite the continued availability of cocaine.  
The present study demonstrates that an MDMA-associated 
stimulus is also required for continued self-administration of MDMA and 
is the first to demonstrate the development of similar conditioned 
reinforcing properties of a stimulus that had been associated with self-
administered MDMA.  Behaviour maintained in the absence of the drug 
stimuli may also indicate that the light stimulus is acting as a 
discriminative stimulus, consequently behaviour may be under stimulus 
control.  Again, this phenomenon is noted for many other drugs of abuse, 
such as cocaine (Weiss et al, 2003), amphetamine (Davis & Smith, 1976), 
and morphine (Davis & Smith, 1976).   
The discriminative ability of drug-associated stimuli to indicate 
the onset or availability of self-administration, resulted  in drug- taking 
behaviour being controlled by these associated stimuli (Beninger et al, 
1981; Van der Kooy, et al, 1983; Foltin & Haney, 2000).  Typically in 
stimuli control studies the discriminative stimuli precede reinforcement; 
however, in the current study behaviour was maintained by a stimulus 
that co-occurred with the infusion of MDMA.  Given the duration of 
infusion delivery / light presentation and the subjective response to 
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MDMA, the light stimulus may have been functioning as a discriminative 
stimulus.   
The ability of drug-associated cues to acquire control over 
behaviour and to lead to drug seeking is a critical characteristic of drug 
abuse (Carter & Tiffany, 1999; Childress et al, 1986; 1988; 1992; 1993; 
1999; O’Brien et al, 1992; Drummond et al, 1990; Foltin & Hanley, 
2000). Accordingly, these data are consistent with the idea that MDMA is 
a drug with high abuse potential. In the present study, continued 
presentation of the light stimulus associated with self-administered 
MDMA infusions rendered rats resistant to extinction of self-
administration behaviour.  
With other drugs of abuse, the ability of drug-associated stimuli to 
control behaviour has been elegantly demonstrated through the use of 
second order schedules (Keheller, 1966; Goldberg, 1973; Goldberg et al, 
1975; Goldberg & Gardner, 1981; Sanchez-Ramos & Schuster, 1977; 
Schindler et al, 2002; Arroyo et al, 1998; Everrit & Robbins, 2000; 
Parkinson et al, 2001; Diciano & Everrit, 2004).  The demonstration of a 
resistance to extinction through presentation of a drug-associated stimulus 
indicates that MDMA may maintain a second-order schedule of 
reinforcement.  This possibility remains an exciting avenue for future 
research.    
The development of conditioned reinforcing effects of drug-
associated stimuli might explain why MDMA self-administration by 
humans remains high despite reports of tolerance to the positive 
subjective effects of the drug (Parrott 2005; Verheyden et al 2003).  Of 
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note, a majority of MDMA users will consume MDMA in specific 
environments and behavior does not generalize easily (Parrott, 2005).  
This might also explain the development of compulsive use among some 
MDMA users (Jansen 1999; Parrott 2005; Von Sydow et al. 2002) since 
stimuli associated with MDMA might maintain drug-taking behavior 
despite the development of tolerance to the positive effects of the drug. In 
some studies, the continued presentation of cues associated with self-
administered drugs enhanced responding maintained by the drug alone 
(Panilio et al., 2000; Weiss et al., 2003; Palmatier et al., 2006).  In the 
present study, the importance of the continued presentation of a stimulus 
associated with self-administered MDMA was also demonstrated and 
operant responding decreased dramatically when this drug-associated 
stimulus was omitted.  In this manner, MDMA-self-administration by 
experienced subjects might come under the same level of stimulus control 
as has been demonstrated in cocaine-, nicotine- and heroin-experienced 
subjects (Panilio et al., 2000; Weiss et al., 2003; Palmatier et al., 2006; 
Chaudhri et al., 2005).  
The fact that extinction of operant responding was delayed by the 
continued presentation of the MDMA-associated light stimulus and that 
MDMA infusions failed to continue to reinforce operant responding when 
the light stimulus was removed suggests a change in the ability of 
MDMA to activate substrates relevant to its reinforcing properties. In 
other studies (Schultz et al. 1992; Fontana et al. 1993; Duvauchelle et al. 
2000; Ito et al. 2000; Carelli 2000; 2004; Schultz 2001), it has been 
demonstrated that following repeated pairings, there is a loss of the 
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capacity of a primary reinforcer to activate dopamine systems and an 
increased response of central dopamine systems to the presentation of the 
stimulus that had been paired with the primary reinforcer. These findings 
have profound implications for compulsive drug taking since they suggest 
that conditioned stimuli rather than primary reinforcers become the 
primary determinants of continued drug seeking.  
Reinstatement of extinguished responding after MDMA prime 
 In the present study the ability of MDMA to reinstate extinguished 
MDMA self-administration behaviours was measured.  Responding was 
produced as both dose-, and schedule-, dependant prior to reinstatement 
studies.  Removal of both the light stimulus and drug stimulus produced a 
rapid reduction in responding.   Experimenter administered MDMA 
reinstating extinguished responding.  Responding on the inactive lever 
remained low and stable throughout the different phases of testing.   
Several studies have reported that priming injections of a self-
administered drug reinstates extinguished drug-taking behaviour. For 
example, experimenter administered cocaine, amphetamine and heroin 
reinstated extinguished responding for animals trained to self-administer 
cocaine  (de Wit and Stewart, 1981; Slikker et al., 1984; Comer et al, 
1993; Worley et al, 1994; Weissenborn et al, 1995), amphetamine 
(Stretch and Gerber, 1975; Ettenberg, 1990) and heroin (de Wit and 
Stewart, 1983; Shaham et al, 1996), respectively.  MDMA has also been 
demonstrated to reinstate responding after amphetamine self-
administration, only in animals previously exposed to MDMA (Morley et 
al 2004).  In the current study, all animals had self-administered MDMA, 
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and reinstatement was robust.    These findings indicate that MDMA may 
be able to reinstate responding for other substances.  Given the high rates 
of poly drug use amongst MDMA users, MDMA use after a period of 
abstinence may initiate drug-seeking behaviours for a variety of 
substances.  The possibility that MDMA use may promote relapse in 
poly-drug users needs further consideration.     
The between session measurement of self-administration, 
extinction and reinstatement behaviours indicates that reinstatement is not 
due to the acute withdrawal effects (Shalev et al, 2002).  In the current 
study, the use of 2-3 days of extinction training and attenuation of 
responding during this period suggests that animals were responding as a 
function of drug stimulus presentation.   Responding produced after 
MDMA administration was dose dependant and 10mg/kg MDMA 
produced double the rate of baseline responding.  Similar findings have 
been reported when other drugs of abuse were self-administered.  For 
example, methamphetamine administration (1mg/kg) produced 
responding approximately double that maintained by 0.06mg/kg/infusion 
(Anggadiredja et al, 2004).  The temporal pattern of responding was dose 
dependently elevated in the first half of the self-administration sessions.  
The production of dose-dependant reinstatement is consistent with other 
reports of drug-primed reinstatement (Self & Nestler, 1998; Stewart, 
2000; Chiamuerla et al, 1996; Shaham et al, 1997; de Wit, 1996; De wit 
& Stewart, 1981).  The use of drug doses higher than those used to 
maintain self-administration, have been regularly used to reinstate 
responding (de Wit, 1996).  While the dose of 10mg/kg may have 
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increased motor activity, responding occurred selectivity on the active 
lever.  The selectivity of this response suggests that animals may have 
been seeking MDMA.     
 The predictive utility of the reinstatement procedure has been well 
established, and therefore, clinical implications of this finding are 
profound. The reinstatement model is widely used to understand factors 
contributing to the ‘relapse’ process of addiction (Shalev et al, 2002; Katz 
et al, 2004).  The return to compulsive drug taking after periods of 
abstinence is a determinant of addiction.   Accordingly, the demonstration 
of MDMA reinstatement suggests that some individuals may be sensitive 
to relapse.  It would be expected that in the future, current or abstinent 
MDMA users may experience relapse to either MDMA use, or poly drug 
use if exposed to MDMA again.  In addition, given the commonalties 
between MDMA self-administration and the self-administration patterns 
and features produced by other commonly abused drugs; these data 
indicate that MDMA does have a significant abuse liability.  Subsequent 
studies would benefit from evaluating the role of dopaminergic agonists 
in reinstating behaviour.  Furthermore, given the wealth of data 
implicating cross-sensization, assessment of reinstatement with other 
substances is required in order to provide a strong understanding of 
widely reported poly drug use in MDMA users.  
Validity of MDMA self-administration 
Underpinning all interpretation is the assumption that MDMA 
self-administration models human MDMA use.   The validity of the 
MDMA self-administration has been questioned due to several features of 
MDMA Self-administration     - 115 - 
 - 115 - 
human MDMA use that are not yet addressed in the MDMA self-
administration literature, including, route of administration, patterns of 
consumption, and human polydrug use (de la Garza et al, 2006).   
 The self-administration paradigm employed used an indwelling 
intravenous catheter to deliver MDMA.  It could be argued that 
intravenous delivery is not consistent with the widely reported oral 
consumption of MDMA (de la Garza et al, 2006).  Intravenous delivery 
produces rapid effects when compared to oral administration, therefore 
increasing the likelihood that a substance be more reinforcing.  MDMA 
is, however, administered intravenously by some people.  For example, 
Topp et al, (1999) report 16% of MDMA users had used MDMA 
intravenously.  Heavy MDMA users can differentiate the subjective 
effects of MDMA based on the route of administration (Solowij et al, 
1992; Topp et al, 1999).  The focus of the current thesis was to explore 
basic parameters of MDMA self-administration.  Future studies may 
benefit from looking at oral MDMA self-administration.    
The current results were produced over daily self-administration 
sessions; in contrast human MDMA consumption occurs predominantly 
in binge patterns (Topp et al, 1999; Winstock et al, 2001).  It is highly 
likely that these parameters may have affected the results.  Self-
administration studies utilizing unlimited access over a long period of 
time and discrete access to MDMA may help to clarify patterns of 
consumption.   
Poly drug use is very common amongst MDMA users (Solowij et 
al, 1992; Forsyth et al, 1996; Davidson & Parrott, 1997; Schifano et al, 
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1998; Topp et al, 1999; Parrott et al, 2000; von Sydow et al, 2002; 
Verheyden et al, 2003; Schooley et al, 2004).  MDMA is rarely used 
alone; with one large study reporting 0.7% of MDMA users consuming 
MDMA alone (Verheyden et al, 2003).  Concurrent acute drug use is 
typically alcohol, cannabis, and amphetamine (Topp et al, 1999; 
Verheyden et al, 2003).  Approximately 40-45% of MDMA users 
concurrently use amphetamines (Solowij et al, 1992; Topp et al, 1999), 
while 45-55% of MDMA users concurrently use marijuana (Solowij et al, 
1992; Topp et al, 1999).  Smoking cannabis is reportedly to ‘pick you up’ 
and ‘bring you down’ in an attempt to prolong peak effects or to 
counteract insomnia (Solowij et al, 1992).  The high use of 
benzodiazepines in the residual phase of MDMA use is also particularly 
common (Topp et al, 1999; Forsyth et al, 1996; Scholey et al, 2004).  The 
current study did not attempt to address issues pertaining to poly drug use 
simply because basic clarification of MDMA self-administration was 
required.  Subsequent research would benefit from systematically looking 
at self-administration of multiple compounds with MDMA and pre-
treatment with other substances.   Given the literature on cross-
sensitisation, the interactions between MDMA and other drugs of abuse is 
a very important avenue for future research.  
Consistency with dominant addictions theories  
 The MDMA self-administration data indicates that MDMA can produce 
behavioural features consistent with other commonly abused substances.  
These behavioural phenomena have been used as an index for the abuse 
potential of illicit substances, suggesting that MDMA is a drug with 
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abuse liability.  Self-administration alone does not provide evidence of 
addiction; rather features of addiction are required to be demonstrated 
within a self-administration paradigm (Robinson, 2004; Deroche –
Gamonet et al, 2004).  At a basic level, the demonstration of reliable 
MDMA self-administration indicates that MDMA functions as a positive 
reinforcer.   Positive reinforcement is an established feature in most 
scientific theories of addiction (Koob et al 2004, 1997; Robinson & 
Berridge, 2000; 2003; Wise & Bozarth, 1987).   
In animals, self-administration of drugs of abuse is mediated by 
the natural reward pathways in the brain – primarily the mesolimbic 
system (Wise, 1981; Koob & Le Moal, 2001; Volkow et al, 1999).  
MDMA self-administration was sensitive to manipulation of the 
dopamine system, indicating that like other psychostimulants, MDMA 
use has a dopaminergic component.  Several theories of addiction have 
focused on aberrations in dopaminergic processing and consequently 
learning, after repeated drug use (Wise, 1996; Koob et al, 1998; Di 
Chiara et al 1999).  It has been clearly demonstrated that increases in 
dopamine are produced after MDMA self-administration (Fitzgerald & 
Reid, 1990).  The demonstration of a rightward shift in the MDMA dose 
effect curve after dopaminergic antagonism provides evidence that the 
dopamine efflux produced during MDMA self-administration mediates 
some of the behavioural effects of MDMA.   
Aberrant learning theories of addiction hypothesise that a lack of 
dopaminergic habituation produces these abnormally strong stimuli-drug 
associations (Di Chiara et al, 1999; Wolf, 2002).  .  The magnitude of the 
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drug- drug stimuli relationship has been proposed to increase the 
incentive motivational aspects of drug taking (Di Chiara et al, 1999; 
Wolf, 2002), and to increase sensitivity to drug associated stimuli.  
Repeated exposure to drug-associated stimuli is widely known to produce 
conditioned highs, conditioned withdrawals and conditioned craving 
(O’Brien et al, 1992; Childress et al, 1988; Eherman et al, 1992).  
MDMA self-administration was sensitive to manipulation of associated 
stimuli, providing an indication that repeated self-administration of 
MDMA produces conditioning effects, and an increase in the salience of 
environmental stimuli associated with MDMA use.  Of interest, in 
humans MDMA consumption is largely context specific (Green et al, 
2003).    The sensitisation towards salient attentional stimuli is theorised 
to underpin the transition from wanting to craving, from abuse to 
dependence (Robinson & Berridge, 1993; 2000; 2001; 2003).   
Alterations in the processing of drug associated stimuli and 
underlying neural substrates after chronic drug use has been suggested to 
render individuals sensitive to the resumption of drug taking behaviours 
after drug consumption has initially ceased (Wolf, 2002; Di Chiara, et al, 
1999; Wise, 1996; Koob, 2006; Weiss, 2005; Nestler, 2002; Kalivas & 
Volkow, 2005).  In the current study, MDMA reinstated responding 
previously maintained by MDMA.  The reinstatement paradigm has been 
used to model aspects of the relapse process in addiction (Shalev et al, 
2002); therefore, the demonstration of MDMA induced reinstatement 
implies that prior MDMA users may be sensitive to the resumption of 
MDMA use after a period of abstinence.  No studies have adequately 
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assessed MDMA produced relapse in humans, however, von Sydow and 
colleagues (2002) did report that a small proportion of MDMA users had 
difficulty remaining abstinent from MDMA.  
The development of tolerance, a behaviour reported with much 
drug addiction, and accounted for by most theories of addiction was not 
systematically investigated in the current study.  Given the commonalties 
between MDMA self-administration and self-administration of other 
psychostimulants, and the applicability of drug addiction theories to 
MDMA self-administration, it would be expected that MDMA 
administration produces tolerance to the subjective effects.   Tolerance 
after chronic MDMA use in humans (Shulgin, 1986; Pertrouka et al, 
1988; Solowij et al, 1992; Davidson & Parrott, 1997; Winstock et al, 
2001; Verhyeden et al, 2003; Parrott, 2005) in primate MDMA self-
administration (Fantegrossi et al, 2004) has been reported.  The role of 
tolerance to MDMA, and the consequential behaviours still need to be 
evaluated within the self-administration paradigm.    
Much debate has occurred over the abuse liability of MDMA in 
the absence of a theoretical framework (De la Garza et al, 2006); rather 
the abuse potential has been measured by the paucity of MDMA self-
administration studies, and consequential lack of behavioural markers of 
abuse potential.  The demonstration of self-administration, and the 
sensitivity of MDMA self-administration to manipulation of 
pharmacological and environment stimuli is consistent with key features 
in all the major theories of addiction providing further evidence that 
MDMA has an abuse potential.   
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Given the commonalities outlined between MDMA and other 
psychostimulants, treatment of MDMA abuse and MDMA –poly drug 
abuse could be similar to empirically validated substance abuse 
treatments.  For example, cue exposure is frequently used in rehabilitation 
centres to desensitise people to the conditioned effects of drug-associated 
stimuli (Seigel & Ramos, 2002; Childress et al, 1988; 1993).  The 
conditioned effects reported here indicate that MDMA users would likely 
benefit from cue exposure treatments to stimuli associated with MDMA 
use.  The use of relapse prevention models also may be beneficial in order 
to prevent relapse (Marlett & Gordon, 1985).  Pharmacologically, the 
acute positive subjective effects of MDMA in humans can be blocked 
using dopamine antagonists (Leitchi & Vollenweider, 2000).  The focus 
of this thesis was to look at factors affecting acquisition and maintenance 
of MDMA self-administration.  These factors are consistent with a 
substance that has abuse liability, and potential to induce relapse.  
Therefore, before any specific treatments, MDMA use needs to firstly be 
specifically addressed in treatment with those who have used MDMA. 
 
Conclusion    
The results reported here provide support for the hypothesis that 
MDMA has an abuse potential, and shares common addictive properties 
with other abused substances.  It is hypothesised that as MDMA 
consumption has increased so too is the likelihood that MDMA users may 
have symptoms of addiction.   
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MDMA consumption has been poorly characterised and query 
over the abuse potential of MDMA has existed.  The central tenet of this 
thesis was to ascertain whether MDMA is self-administered and whether 
MDMA self-administration has features of addiction.  Self-administration 
of MDMA was obtained and tested.  Dopamine antagonism indicated that 
dopaminergic mechanisms are involved in the reinforcing effects of 
MDMA.  Manipulation of drug and drug associated stimuli provided 
evidence that stimuli associated with MDMA acquire reinforcing 
properties.  Reinstatement of responding previously maintained by 
MDMA was also obtained upon re-exposure to MDMA.  The behaviours 
reported are comparable to those produced by other psychostimulants, 
and consistent with theories of addiction, and definitions of abuse 
potential.  Given the increases in MDMA consumption over the past two 
decades, it is likely that problems associated specifically with MDMA 
will arise.  As such, further investigation into MDMA self-administration 
is warranted and will provide further information for clinical and 
neuropsychological gain.       
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